HARRIS & HARRIS GROUP INC /NY/
10-K, 1999-03-26
Previous: BLACKROCK 1999 TERM TRUST INC, DEF 14A, 1999-03-26
Next: HARRIS & HARRIS GROUP INC /NY/, DEF 14A, 1999-03-26



                           SECURITIES AND EXCHANGE COMMISSION
                                 Washington, D. C.  20549

                                        Form 10-K

                          Annual Report Pursuant to Section 13
                    or 15(d) of the Securities Exchange Act of 1934

For the fiscal year ended                      Commission File No. 0-11576
December 31, 1998

                              HARRIS & HARRIS GROUP, INC.
- -----------------------------------------------------------------------------
                (Exact Name of Registrant Specified in Its Charter)
          
          New York                                   13-3119827
- ------------------------------------     ------------------------------------
 (State or Other Jurisdiction of         (I.R.S. Employer Identification No.)
  Incorporation or Organization)                      

One Rockefeller Plaza, Rockefeller Center, New York, New York        10020
- -------------------------------------------------------------      ----------
            (Address of Principal Executive Offices)               (Zip Code)

Registrant's telephone number, including area code       (212) 332-3600
                                                         --------------
  Securities registered pursuant to Section 12(b) of the Act:   None

  Securities registered pursuant to Section 12(g) of the Act:

                          Common Stock $ .01 par value
- -----------------------------------------------------------------------------
                                 (Title of class)

    Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days. Yes [X]   No [  ]

    Indicate by check mark if disclosure of delinquent filers pursuant to 
Item 405 of Regulation S-K is not contained herein, and will not be 
contained, to the best of registrant's knowledge, in definitive proxy or 
information statements incorporated by reference in Part III of this Form 
10-K or any amendment to this Form 10-K. [X]

    The aggregate market value of the Common Stock held by non-affiliates of
Registrant as of March 5, 1999 was $17,230,640  based on the last sale price 
as quoted by Nasdaq National Market on such date (only officers and 
directors are considered affiliates for this calculation).

    As of March 5, 1999, the registrant had 10,426,648 shares of common stock,
par value $.01 per share, outstanding.





                              TABLE OF CONTENTS

                                                                       Page   
PART I                                                 

   Item 1.   Business. . . . . . . . . . . . . . . . . . . . . . . .     1
   Item 2.   Properties. . . . . . . . . . . . . . . . . . . . . . .     7
   Item 3.   Legal Proceedings . . . . . . . . . . . . . . . . . . .     7
   Item 4.   Submission of Matters to a Vote of Security Holders . .     7
     

PART II

   Item 5.   Market for Company's Common Equity and Related
               Stockholder Matters . . . . . . . . . . . . . . . . .     8
   Item 6.   Selected Financial Data . . . . . . . . . . . . . . . .     9
   Item 7.   Management's Discussion and Analysis of Financial
               Condition and Results of Operations . . . . . . . . .    10
   Item 7a.  Quantitative and Qualitative Disclosures About Market
                Risk . . . . . . . . . . . . . . . . . . . . . . . .    20
   Item 8.   Financial Statements and Supplementary Data . . . . . .    21
   Item 9.   Disagreements on Accounting and Financial Disclosure. .    42


PART III

   Item 10.  Directors and Executive Officers of the Company . . . .    42
   Item 11.  Executive Compensation. . . . . . . . . . . . . . . . .    42
   Item 12.  Security Ownership of Certain Beneficial Owners
               and Management. . . . . . . . . . . . . . . . . . . .    42
   Item 13.  Certain Relationships and Related Transactions. . . . .    42

PART IV

   Item 14.  Exhibits, Financial Statements, Schedules and 
               Reports on Form 8-K . . . . . . . . . . . . . . . . .    43

   Signatures. . . . . . . . . . . . . . . . . . . . . . . . . . . .    45

   Exhibit Index . . . . . . . . . . . . . . . . . . . . . . . . . .    47



                                      PART I

Item 1.     Business

     Harris & Harris Group, Inc. (the "Registrant" or "Company") is a venture
capital investment company, operating as a Business Development Company ("BDC")
under the Investment Company Act of 1940 (the "1940 Act").  The Company's 
objective is to achieve long-term capital appreciation, rather than current 
income, from its investments.  The Company has invested a substantial 
portion of its assets in private development stage or start-up companies and 
in the development of new technologies in a broad range of industry segments.
These private businesses tend to be thinly capitalized, unproven, small 
companies that lack management depth and have not attained profitability or 
have no history of operations.  The Company may also invest, to the extent 
permitted under the 1940 Act, in publicly traded securities, including high 
risk securities as well as investment grade securities.  The Company may 
participate in expansion financing and leveraged buyout financing
of more mature operating companies as well as other investments.  As a 
venture capital company, the Company invests in and provides managerial 
assistance to its private investees which, in its opinion, have significant 
potential for growth.  There is no assurance that the Company's investment 
objective will be achieved. 

     The Company was incorporated under the laws of the State of New York in
August 1981.  Prior to September 30, 1992, the Company had a class of 
securities registered, and filed under the reporting requirements, of the 
Securities Exchange Act of 1934 (the "1934 Act") as an operating company.  
On that date the Company commenced operations as a closed-end, non-
diversified investment company under the 1940 Act.  On July 26, 1995, the 
Company elected to become a BDC subject to the provisions of Sections 55 
through 65 of the 1940 Act.  As a BDC, the Company operates as an internally 
managed investment company whereby its officers and employees, under the 
general supervision of its Board of Directors, conduct its operations.

     On September 25, 1997, the Company's Board of Directors approved a proposal
to seek qualification of the Company as a Regulated Investment Company ("RIC") 
under Sub-Chapter M of the Internal Revenue Code (the "Code").  At that time, 
the Company was taxable under Sub-Chapter C of the Code (a "C Corporation").  
On April 8, 1998, the Company announced that it had received a certification 
from the Securities and Exchange Commission ("SEC") for 1997 relating to the 
Company's status under section 851(e) of the Code.  That certification was 
necessary for the Company to qualify as a RIC for 1998 and subsequent 
taxable years.

     Pursuant to the Company's receipt of the section 851(e) certification 
and its intention to qualify as a RIC, the Company's Board of Directors 
declared and paid a one-time cash dividend of $0.75 per share, for a total 
of $8,019,728, to meet one of the Company's requirements for qualification 
for Sub-Chapter M tax treatment.  On February 17, 1999, the Company received 
rulings from the Internal Revenue Service (the "IRS") regarding other issues 
relevant to the Company's tax status as a RIC.  (See "Note 6 of Notes to 
Financial Statements" contained in "Item 8. Financial Statements and 
Supplementary Data" & "Item 7 - Management's Discussion and Analysis of 
Financial Condition and Results of Operations -- Recent Developments - Sub-
Chapter M Status".)
                                      1

     The qualification of the Company as a RIC under Sub-Chapter M of the Code
depends on it satisfying certain technical requirements regarding its income,
investment portfolio, and distributions.  The Company was unable to satisfy 
these requirements for the 1998 tax year owing to the nature of the Company's
ownership interest in one of its investee companies, and therefore it will 
not elect Sub-Chapter M status for 1998.  In addition, because the Company 
realized taxablelosses in 1998, it was not strategically advantageous for 
the Company to elect Sub-Chapter M tax status for 1998.  Moreover, the 
Company received a tax opinion in 1998 that the Company interprets to mean 
that its tax-loss carryforward at December 31, 1998 of approximately $7.1 
million (resulting in a tax credit of approximately $2.5 million) would be 
applicable as a qualifying RIC to its unrealized gains as of December 31, 
1998.  That opinion was confirmed in one of the rulings received from the 
IRS in February 1999.

     The Company changed the nature of its ownership interest in the non-
qualifying investee company effective January 1, 1999 in order to meet the 
Sub-Chapter M requirements.  However, there can be no assurance that the 
Company will qualify for Sub-Chapter M treatment for 1999 or subsequent 
years.  In addition, under certain circumstances, even if the Company were 
qualified for Sub-Chapter M treatment in 1999 and elected Sub-Chapter M 
treatment for that year, the Company might take action in a subsequent year 
to ensure that it would be taxed in that subsequent year as a C Corporation, 
rather than a RIC.

Venture Capital Investments

     The Company has invested a substantial portion of its assets in private
development stage or start-up companies. The Company may initially own 100 
percent of the securities of a start-up investee company for a period of 
time and may control such company for a substantial period.  In connection 
with its venture capital investments, the Company may be involved in 
recruiting management, formulating operating strategies, product development,
marketing and advertising, assisting in financial plans, as well as providing
management in the initial start-up stages and establishing corporate goals. 
The Company may assist in raising additional capital for such companies from
other potential investors and may subordinate its own investment to that of 
other investors.  The Company may introduce such companies to potential 
joint-venture partners, suppliers and customers. In addition, the Company 
may assist in establishing relationships with investment bankers and other 
professionals.  The Company may also assist with mergers and acquisitions.  
The Company may also find it necessary or appropriate to provide additional 
capital of its own.  The Company may derive income from such companies for 
the performance of any of the above services. Because of the speculative 
nature of these investments and the lack of any market for such securities, 
there is significantly greater risk of loss than is the case with traditional
investment securities.  The Company expects that some of its venture
capital investments will be a complete loss or will be unprofitable and that
some will appear likely to become successful, but never realize their 
potential.  The Company has in the past sought, and will continue in the 
future to seek, investments that offer the potential for significantly 
higher returns but that involve a significantly greater degree of risk than 
other investments.
                                     2
     
     The Company may control an investee company for which it has provided 
venture capital, or it may be represented on the company's board of 
directors by one or more of its officers or directors, who may also serve 
as officers of such company. Particularly during the early stages of an 
investment, the Company may in effect be conducting the operations of the 
investee company.  As a venture company emerges from the developmental stage
with greater management depth and experience, the Company expects that its 
role in the company's operations will diminish. The Company seeks to assist 
each investee company in establishing its own independent capitalization, 
management and board of directors. The Company expects to be able to reduce 
its active involvement in the management of its investment in those
start-up companies that become successful by a liquidity event, such as a 
public offering or sale of a company.

     The Company has invested a substantial portion of its assets in 
securities that do not pay interest or dividends and that are subject to 
legal or contractual restrictions on resale that may adversely affect the 
liquidity and marketability of such securities.  

     In addition to the information discussed above, please see "Item 8. 
Financial Statements and Supplementary Data."

Intellectual Property

     The Company believes there is a role for organizations like itself that 
can assist in technology transfer.  Scientists and institutions that develop 
and patent intellectual property increasingly seek the rewards of 
entrepreneurial commercialization of their inventions, particularly as 
governmental, philanthropic and industrial funding for research has become 
harder to obtain. The Company believes that several factors combine to give 
it a high value-added role to play in the commercialization of technology: 
its experience in organizing and developing successful new companies; its 
willingness to invest its own capital at the highest risk- seed stage; its 
access to high-grade institutional sources of intellectual property; its 
experience in mergers, acquisitions and divestitures; its access to and 
knowledge of the capital markets; and its willingness to do as much of the
early work as it is qualified to do.

     The Company invests principally in securities issued by companies involved
in: 1) research and development of a technology and/or obtaining licensing 
rights to intellectual property or patents; 2) outright acquisition of 
intellectual property or patents; and 3) formation and funding of companies 
or joint ventures to commercialize intellectual property.  Income from the 
Company's investments in intellectual property or its development may take 
the form of participation in licensing or royalty income or some other form 
of remuneration.  At some point during the commercialization of a technology,
the Company's investment may be transformed into ownership of securities of 
a development stage or start-up company as discussed above. Investing in 
intellectual property is highly risky.

                                    3

Illiquidity of Investments

     Many of the Company's investments consist of securities acquired directly
from the issuer in private transactions.  These investments may be subject to
restrictions on resale or otherwise be illiquid.  The Company does not 
anticipate that there will be any established trading market for such 
securities.  Additionally, many of the securities that the Company may 
invest in will not be eligible for sale to the public without registration 
under the Securities Act of 1933, as amended, which could prevent or delay 
any sale by the Company of such investments or reduce the amount of proceeds 
that might otherwise be realized therefrom.  Restricted securities generally 
sell at a price lower than similar securities not subject to restrictions on 
resale.  Further, even if a portfolio company registers its securities and 
becomes a reporting company under the 1934 Act, the Company may be considered
an insider by virtue of its board representation or otherwise and would be 
restricted in sales of such company's securities.
     
Managerial Assistance

     The Company generally is required by the 1940 Act to make significant
managerial assistance available with respect to investee companies that the 
Company treats as qualifying assets for purposes of the 70 percent test 
(see "Regulation"). "Making available significant managerial assistance" as 
defined in the 1940 Act with respect to a BDC such as the Company means (a) 
any arrangement whereby a BDC, through its directors, officers, employees or
general partners, offers to provide, and if accepted, does so provide, 
significant guidance and counsel concerning the management, operations, or 
business objectives and policies of a portfolio company; or (b) the exercise 
by a BDC of a controlling influence over the management or policies of a 
portfolio company by a BDC acting individually or as a part of a group 
acting together which controls such portfolio company.  The Company believes
that providing managerial assistance to its investees is critical to its 
business development activities. The nature, timing and amount of managerial 
assistance provided by the Company vary depending upon the particular 
requirements of each investee company.

     The Company may be involved with its investees in recruiting management,
product planning, marketing and advertising and the development of financial 
plans, operating strategies and corporate goals.  In this connection, the 
Company may assist clients in developing and utilizing accounting procedures 
to efficiently and accurately record transactions in books of account, which 
will facilitate asset and cost control and the ready determination of results
of operations.  The Company also seeks capital for its investees from other 
potential investors and occasionally subordinates its own investment to those
of other investors.  The Company may introduce its investees to potential 
suppliers, customers and joint venture partners and assists its investees in 
establishing relationships with commercial and investment bankers and other 
professionals, including management consultants, recruiters, legal counsel 
and independent accountants.  The Company also assists with joint ventures, 
acquisitions and mergers.

     In connection with its managerial assistance, the Company may be 
represented by one or more of its officers or directors on the board of 
directors of an investee.  As an investment matures and the investee
develops management depth and experience, the Company's role ordinarily will 

                                      4

become progressively less active.  However, when the Company owns or acquires 
a substantial proportion of a more mature investee company's equity, the 
Company may remain active in and may initiate planning of major transactions 
by the investee.  The Company typically seeks to assist each investee 
company in establishing its own independent and effective board of directors 
and management.

Need for Follow-On Investments

     Following its initial investment in investees, the Company has made and
anticipates that it will continue to make additional investments in such 
investees as "follow-on" investments, in order to increase its investment in
an investee, and may exercise warrants, options or convertible securities 
that were acquired in the original financing.  Such follow-on investments 
may be made for a variety of reasons including: 1) to increase the Company's
exposure to an investee, 2) to acquire securities issued as a result of 
exercising convertible securities that were purchased in the original 
financing, 3) to preserve the Company's proportionate ownership in a 
subsequent financing, or 4) to attempt to preserve or enhance the value of 
the Company's investment.  There can be no assurance that the Company will 
make follow-on investments or have sufficient funds to make such investments;
the Company has the discretion to make any follow-on investments as it
determines, subject to the availability of capital resources.  The failure 
to make such follow-on investments may, in certain circumstances, jeopardize
the continued viability of an investee and the Company's initial investment,
or may result in a missed opportunity for the Company to increase its 
participation in a successful operation.  Even if the Company has sufficient
capital to make a desired follow-on investment, the Company may under 
certain circumstances be inhibited from doing so if such an investment would 
result in non-compliance with BDC or RIC regulations.

Competition

     Numerous companies and individuals are engaged in the venture capital
business and such business is intensely competitive.  Most of the competitors
have significantly greater experience, resources and managerial capabilities 
than the Company and are therefore in a better position than the Company to 
obtain access to attractive venture capital investments.

Regulation

     The Small Business Investment Incentive Act of 1980 added the provisions of
the 1940 Act applicable to BDC's, which are a special type of closed-end 
investment company.  After filing its election to be treated as a BDC, a 
company may not withdraw its election without first obtaining the approval 
of holders of a majority of its outstanding voting securities.  The following
is a brief description of the 1940 Act provisions applicable to BDC's, and is
qualified in its entirety by reference to the full text of the 1940 Act and 
the rules issued thereunder by the SEC.

     Generally, to be eligible to elect BDC status, a company must primarily
engage in the business of furnishing capital and managerial expertise to 
companies which do not have ready access to capital through conventional 
financial channels.  Such portfolio companies are termed "eligible portfolio 

                                       5

companies."  In general, in order to qualify as a BDC, a company must (i) be 
a domestic company; (ii) have registered a class of its securities pursuant 
to Section 12 of the 1934 Act; (iii) operate for the purpose of investing in
the securities of certain types of portfolio companies, namely, immature or 
emerging companies and businesses suffering or just recovering from financial
distress (see following paragraph); (iv) make available significant 
managerial assistance to such portfolio companies; (v) have a majority of 
"disinterested" directors (as defined in the 1940 Act); and (vi) file a 
proper notice of election with the SEC.

     An eligible portfolio company generally is a domestic company that is 
not an investment company and that (i) does not have a class of equity 
securities on which "margin" credit can be extended or (ii) is controlled 
by a BDC (control under the 1940 Act is presumed to exist where a BDC owns 
at least 25 percent of the outstanding voting securities of the investee).

     The 1940 Act prohibits or restricts companies subject to the 1940 Act 
from investing in certain types of companies, such as brokerage firms, 
insurance companies, investment banking firms and investment companies.  
Moreover, the 1940 Act requires that at least 70 percent of the value of 
the Company's assets consist of qualifying assets.  Qualifying assets 
include: (i) securities of companies that were eligible portfolio companies 
at the time the Company acquired their securities; (ii) securities of 
bankrupt or insolvent companies that were eligible at the time of the 
Company's initial investment in those companies; (iii) securities received 
in exchange for or distributed in or with respect to any of the foregoing; 
and (iv) cash items, government securities and high quality short-term
debt.  The 1940 Act also places restrictions on the nature of the 
transactions in which, and the persons from whom, securities can be 
purchased in order for the securities to be considered qualifying assets. 

     The Company is permitted by the 1940 Act, under specified conditions, to
issue multiple classes of senior debt and a single class of preferred stock 
if its asset coverage, as defined in the 1940 Act, is at least 200 percent 
after the issuance of the debt or the preferred stock (i.e., such senior 
securities may not be in excess of its net assets). 

     The Company may sell its securities at a price that is below the 
prevailing net asset value per share only after a majority of its 
disinterested directors has determined that such sale would be in the best 
interest of the Company and its stockholders and upon the approval by the 
holders of a majority of its outstanding voting securities, including a 
majority of the voting securities held by non-affiliated persons.  If the 
offering of the securities is underwritten, a majority of the disinterested 
directors must determine in good faith that the price of the securities 
being sold is not less than a price which closely approximates market
value of the securities, less any distribution discount or commission.  As 
defined by the 1940 Act, the term "majority of the Company's outstanding 
voting securities" means the vote of (i) 67 percent or more of the Company's
Common Stock present at the meeting, if the holders of more than 50 percent 
of the outstanding Common Stock are present or represented by proxy or (ii) 
more than 50 percent of the Company's outstanding Common Stock, whichever is
less.
                                     6
   
     Certain transactions involving certain closely related persons of the
Company, including its directors, officers and employees, may require the 
prior approval of the SEC. However, the 1940 Act ordinarily does not restrict
transactions between the Company and investee companies.

     On September 25, 1997, the Company's Board of Directors approved a 
proposal to seek qualification of the Company as a RIC under Sub-Chapter M 
of the Code.  The Company was unable to satisfy the requirements for Sub-
Chapter M for the 1998 tax year.  (See "Item 7.  Management's Discussion and
Analysis of Financial Condition and Results of Operations -- Recent 
Developments - Sub Chapter M Status.")  There can be no assurance that the 
Company will qualify for Sub-Chapter M treatment for 1999 or subsequent 
years.  In addition, under certain circumstances, even if the Company were 
qualified for Sub-Chapter M treatment in 1999 and elected Sub-Chapter M 
treatment for that year, the Company might take action in a subsequent year 
to ensure that it would be taxed in that subsequent year as a C Corporation,
rather than a RIC.

Employees

     The Company currently employs four full-time employees.

Item 2.   Properties

     The Company maintains its offices at One Rockefeller Plaza, Suite 1430, 
New York, New York 10020, where it leases approximately 4,700 square feet of
office space pursuant to a lease agreement expiring in 2003.  A portion of 
this space was sublet in 1997 and 1998 to an early-stage company in which 
the Company had an equity interest.  See "Note 7 to the Financial Statements"
and Schedules contained in "Item 8.  Financial Statements and Supplementary 
Data."

Item 3.   Legal Proceedings

     None.

Item 4.   Submission of Matters to a Vote of Security Holders

     The Company did not submit any matters to a vote of its shareholders 
during the fourth quarter of the 1998 fiscal year.

                                     7

                                 PART II

Item 5.   Market for Company's Common Equity and Related Stockholder Matters

Stock Transfer Agent

     The Bank of New York, 101 Barclay Street, Suite 12W, New York, New York
10286 (Telephone 800-524-4458, Attention: Ms. Diane Ajjan) serves as transfer
agent for the Company's common stock. Certificates to be transferred should be
mailed directly to the transfer agent, preferably by registered mail.

Market Prices

     The Company's common stock is traded on the Nasdaq National Market under
the symbol "HHGP."  The following table sets forth the range of the high and 
low selling  price of the Company's shares during each quarter of the last 
two years, as reported by the National Association of Securities Dealers, 
Inc.  The quarterly stock prices quoted represent interdealer quotations and
do not include markups, markdowns or commissions.

<TABLE>
          <S>                           <C>       <C>
          1998 Quarter Ending           Low       High
          March 31                      $2.1875   $3.4375
          June 30                       $2.2500   $3.6875
          September 30                  $1.2500   $2.3750
          December 31                   $1.1250   $1.5938

          1997 Quarter Ending           Low       High
          March 31                      $3.3750   $5.1250
          June 30                       $3.5000   $4.8125
          September 30                  $2.5000   $3.7500
          December 31                   $2.5000   $4.0000
</TABLE>

     On September 25, 1997, the Company's Board of Directors approved a 
proposal to seek qualification of the Company as a RIC under Sub-Chapter M 
of the Code.  To initially qualify as a RIC, the Company had, among other 
things, to pay a dividend to shareholders equal to the Company's cumulative 
realized earnings and profits ("E&P") from its pre-RIC taxable years.  The 
Company paid a $0.75 dividend on May 12, 1998 to shareholders of record on 
April 27, 1998.  (See "Item 7. Management's Discussion and Analysis of 
Financial Condition and Results of Operations -- Recent Developments - 
Sub-Chapter M Status" and "Note 6 of Notes to Financial Statements" 
contained in "Item 8. Financial Statements and Supplementary Data".)

     On February 22, 1999, NBX Corporation announced that it had agreed to be
acquired by 3Com Corporation for approximately $90 million in cash plus
additional consideration for employees of NBX.  This transaction was 
effective on March 5, 1999 and closed on March 8, 1999.  On closing, the 
Company received a total of $12,432,940 in cash, of which $1,475,276 was 
placed in a one-year escrow.  On February 23, 1999, the Board of Directors 
of the Company declared a cash dividend of $0.35 per share (approximately 
$3.7 million) to shareholders of record on March 19, 1999, payable on March 
25, 1999.  Prior to 1998, the Company had not paid dividends since 1991.

                                       8

Recent Sales of Unregistered Securities

     The Company has not sold unregistered shares for the years ended December
31, 1998 and 1997 other than the restricted common stock shares sold to 
Directors as part of their compensation program.  In 1997, the Board of 
Directors approved that effective January 1, 1998, 50 percent of all 
Director fees be used to purchase Company common stock directly from the 
Company.  During 1998, the Directors have purchased a total of 24,491 shares.
(See "Note 4 of Notes To Financial Statements" contained in "Item 8.  
Financial Statements and Supplementary Data.")  On March 1, 1999, the 
Directors voted to purchase their shares in the open market rather than 
directly from the Company.

Shareholders

     As of February 26, 1999, there were approximately 164 holders of record 
of the Company's common stock which, the Company has been informed, hold the
Company's common stock for approximately 2,000 beneficial owners.

Item 6.   Selected Financial Data

     The following tables should be read in conjunction with the Financial
Statements and Schedules included in Item 8 of this Form 10-K.

<TABLE>
<CAPTION>
                            BALANCE SHEET DATA
                   Financial Position as of December 31:

<S>            <C>          <C>          <C>          <C>          <C>
                      1998         1997         1996         1995         1994

Total assets   $25,358,859  $39,273,784  $38,555,290  $37,524,555  $32,044,073

Total 
 liabilities   $ 2,802,150  $ 5,618,850  $ 2,622,687  $   962,646  $   733,271

Net asset 
 value         $22,556,709  $33,654,934  $35,932,603  $36,561,909  $31,310,802

Net asset 
 value per 
 share         $      2.13  $      3.15  $      3.44  $      3.54  $      3.43

Shares 
 outstanding    10,591,232   10,692,971   10,442,682   10,333,902    9,136,747

                  Operating Data for year ended December 31:

                      1998         1997          1996        1995        1994

Investment 
 income        $   635,486  $   614,046  $ 1,013,417  $ 1,109,517  $   820,276

Net operating 
 loss           (2,765,112)  (1,498,141)  (1,291,065)  (1,099,409)  (2,278,882)

Net realized 
 (loss) gain on           
 investments    (1,768,528)  (2,079,677)  (2,465,175)   1,371,349       96,856

Net realized
 (loss) income  (4,533,640)  (3,577,818)  (3,756,240)     271,940   (2,182,026)

Net increase
 (decrease) in
 unrealized 
 appreciation
 on investments  1,655,830      969,243    2,967,248      158,219     (886,040)

Net (decrease)
 increase in
 net assets
 resulting from 
 operations     (2,877,810)  (2,608,575)    (788,992)     430,159   (3,068,066)

(Decrease)
 increase in net
 assets resulting
 from operations
 per outstanding 
 share          $    (0.27)  $    (0.24)  $    (0.08)  $     0.04  $     (0.34)

</TABLE>
                                         9

Item 7. Management's Discussion and Analysis of Financial Condition 
        and Results of Operations

Statement of Operations
     
    The Company accounts for its operations under Generally Accepted Accounting
Principles for investment companies.  On this basis, the principal measure of 
its financial performance is captioned "Net (decrease) increase in net assets 
resulting from operations," which is the sum of three elements.  The first 
element is "Net operating loss," which is the difference between the 
Company's income from interest, dividends, fees and other income and its 
operating expenses, net of applicable income tax benefit (provision).  The 
second element is "Net realized loss on investments," which is the difference
between the proceeds received from dispositions of portfolio securities and 
their stated cost, net of applicable income tax (benefits) provisions.  These
two elements are combined in the Company's financial statements and reported 
as "Net realized loss."  The  third element, "Net increase in unrealized 
appreciation on investments," is the net change in the fair value of the 
Company's investment portfolio, net of increase (decrease) in deferred
income taxes that would become payable if the unrealized appreciation were 
realized through the sale or other disposition of the investment portfolio.

    "Net realized loss on investments" and "Net increase in unrealized
appreciation on investments" are directly related.  When a security is sold 
to realize a (loss) gain, net unrealized appreciation (increases) decreases 
and net realized gain (decreases) increases. 

Financial Condition

    The Company's total assets and net assets were $25,358,859 and 
$22,556,709 at December 31, 1998, respectively, versus $39,273,784 and 
$33,654,934 at December 31, 1997, respectively.  The decrease is primarily 
owing to: 1) the payment of a one-time cash dividend of $8,019,728 to meet 
one of the Company's requirements for qualification for Sub-Chapter M 
treatment; 2) the payment of the Company's outstanding balance on the Demand
Promissory Note of $4,000,000, which reduced the Company's total assets in 
1998; and 3) the decrease of $2,877,810 as a result of operations.  (See 
"Statement of Operations" contained in "Item 8. Financial Statements and 
Supplementary Data".)

    Net asset value per share ("NAV") was $2.13 at December 31, 1998, versus 
$3.15 at December 31, 1997.  NAV was reduced $0.75 by the cash dividend paid 
by the Company in 1998.

    The Company's shares outstanding as of December 31, 1998 were 10,591,232,
versus 10,692,971 at December 31, 1997.  The Company's outstanding shares were
reduced as a result of its repurchase in the open market of a total of 126,230
shares as of December 31, 1998.  However, the treasury shares were then 
decreased by purchases of Company stock by directors with 50 percent of 
their director compensation.  (See "Note 4 of Notes to Financial Statements"
contained in "Item 8. Financial Statements and Supplementary Data".)

                                     10

    The Company's financial condition is dependent on the success of its
investments.  The Company has invested a substantial portion of its assets in
private development stage or start-up companies.  These private businesses 
tend to be thinly capitalized, unproven, small companies that lack management
depth or have no history of operations.  At December 31, 1998, $19,562,386 or
77 percent of the Company's total assets consisted of investments at fair 
value in private businesses, of which net unrealized appreciation was 
$10,250,204 before taxes.  At December 31, 1997, $13,222,857 or 34 percent 
of the Company's total assets consisted of investments at fair value in 
private businesses, of which net unrealized appreciation was $2,464,795 
before taxes.  The increase in the percentage of private investments from 
34 percent in 1997 to 77 percent in 1998 is primarily owing to 1) an 
increase in the value of several private investments; 2) the payment of the 
Company's outstanding balance on the Demand Promissory Note of
$4,000,000, which reduced the Company's total assets in 1998; 3) the decrease 
of $2,877,810 as a result of operations (See "Statement of Operations" 
contained in "Item 8. Financial Statements and Supplementary Data"); and 
4) the payment of a one-time cash dividend of $8,019,728 to meet one of the 
Company's requirements for qualification for Sub-Chapter M treatment.

    A summary of the Company's investment portfolio is as follows:

<TABLE>
<S>                                <C>                 <C>
                                   December 31, 1998   December 31, 1997

Investments, at cost                     $14,124,643         $30,500,498
Unrealized appreciation                   10,407,548           8,158,732
                                         -----------         -----------
Investments, at fair value               $24,532,191         $38,659,230
__________________                       ===========         ===========
The accumulated unrealized appreciation on investments net of deferred taxes 
is $6,996,664 at December 31, 1998, versus $5,340,834 at December 31, 1997.
</TABLE>

    Following an initial investment in a private company, the Company may 
make additional investments in such investee in order to: (1) increase its 
ownership percentage; (2) exercise warrants or options that were acquired 
in a prior financing; (3) preserve the Company's proportionate ownership in 
a subsequent financing; or (4) attempt to preserve or enhance the value of 
the Company's investment.  Such additional investments are referred to as 
"follow-on" investments. There can be no assurance that the Company will 
make follow-on investments or have sufficient funds to make additional 
investments. The failure to make such follow-on investments could jeopardize
the viability of the investee company and the Company's investment or could 
result in a missed opportunity for the Company to participate to a greater 
extent in an investee's successful operations.  The Company attempts to 
maintain adequate liquid capital to make follow-on investments in its private
investee portfolio companies.  The Company may elect not to make a
follow-on investment either because it does not want to increase its 
concentration of risk, because it prefers other opportunities, or because it
is inhibited by compliance with BDC or RIC requirements, even though the 
follow-on investment opportunity appears attractive.

                                   11

     The following table is a summary of the cash investments made by the 
Company in its private placement portfolio during the year ended December 
31, 1998:

<TABLE>
     <S>                                 <C>
     New Investments:                         Amount
     InSite Marketing Technology, Inc.   $   500,000

     Follow-on Investments:                         
     MultiTarget, Inc.                  $     51,802

     Loans:
     BioSupplyNet, Inc. (SciQuest,Inc.) $    250,000                  
     NBX Corporation                          10,000                          
                                         -----------
          Sub-total                     $    260,000

     Interest on Loans*:
     NeuroMetrix, Inc.                  $     48,100                  
     Voice Control Systems, Inc.              17,453              
                                        ------------
          Sub-total                     $     65,553

     Exercise of Warrants Held:
     Voice Control Systems, Inc.        $     82,953
                                        ------------

     Total                              $    960,308
                                        ============

  *The Company received additional shares in NeuroMetrix, Inc. and Voice
Control Systems, Inc. in exchange for the accrued interest on its loans.

</TABLE>

Results of Operations

Investment Income and Expenses:

    The Company had a net operating loss of $2,765,112 in 1998, $1,498,141 in
1997 and $1,291,065 in 1996.  The Company's investment objective is to achieve
long-term capital appreciation rather than current income from its investments. 
Therefore, a significant portion of the investment portfolio is structured to
maximize the potential for capital appreciation and provides little or no 
current yield in the form of dividends or interest.  The Company does earn 
interest income from fixed-income securities, including U.S. Government 
Obligations.  The amount of interest income earned varies based upon the 
average balance of the Company's fixed-income portfolio and the total 
average yield on this portfolio.  
  
    The Company had total investment income of $635,486 in 1998, $614,046 in 
1997 and $1,013,417 in 1996.  The Company had interest income from fixed-
income securities of $355,591 in 1998, $490,807 in 1997 and $803,819 in 1996.
The decrease from 1997 to 1998 of $135,216 or 27.5 percent is a result of a 
decline in the balance of the Company's fixed-income portfolio as a result 
of the dividend, operating expenses and additional investments in non-income
producing private portfolio investments. The decrease from 1996 to 1997 of 
$313,012 or 38.9 percent is a result of the decline of the Company's fixed-
income portfolio as a result of operating expenses and additional investments
in non-income producing private portfolio investments.  The Company also 
received consulting and administrative fees which totaled $29,870 in 1997 
and $68,185 in 1996.  The Company did not receive any consulting or 
administrative fees in 1998.

                                12

    The Company had interest income from affiliated companies of $124,877 in
1998, $40,000 in 1997 and $40,779 in 1996.  The increase from 1997 to 1998 of
$84,877 or 212.2 percent is owing to the receipt of interest income (either in
funds or additional shares) on loans to investee companies and the increase in
loans and outstanding lines of credit to investee companies, principally
NeuroMetrix, Inc. and BioSupplyNet, Inc. (which in 1998 was merged with 
SciQuest,Inc.).

    The Company had other income of $102,468 in 1998, $869 in 1997 and 
$92,610 in 1996.  The increase of $101,599 or 116.9 percent from 1997 to 
1998 is a result of the receipt of $88,000 from BioSupplyNet to reimburse 
the Company for consulting fees paid and expensed by the Company in 1996 as 
part of the investment costs of BioSupplyNet.

    Also in 1998 and 1997, the Company received or accrued dividends of 
$50,000 and $52,500 from its investment in PHZ Capital Partners, L.P.

    Operating expenses were $3,634,786 in 1998, $3,045,290 in 1997 and 
$2,985,316 in 1996.  The increase from 1997 to 1998 of $589,496 or 19.4% is 
primarily owing to: an increase in accrual for the Company's profit-sharing 
plan of $899,751 or 112.3% over the prior year (See "Note 3 of Notes to 
Financial Statements" contained in "Item 8. Financial Statements and 
Supplementary Data"); the final payment on the Harris & Harris Group Senior 
Professorship Pledge to the Massachusetts Institute of Technology of 
$728,862; mitigated by a decrease in salaries and benefits of $676,136 or 
44.9%.  To date, no actual payments have been made under the Company's
profit-sharing plan.

    The increase from 1996 to 1997 of $59,974 or 2.0%  is primarily owing 
to: the accrual of $423,808 for the Company's profit-sharing plan; 
restructuring expenses of $100,000 incurred by the Company as a result of 
researching the conversion to RIC status; mitigated by a decrease in overall
expenses as a result of the Company's effort to cut expenses.  Most of the 
Company's operating expenses were related to employee and director 
compensation, office and rent expenses and consulting and professional fees 
(primarily legal and accounting fees).  To date, no actual payments have 
been made under the Company's profit-sharing plan.

    The Company has in the past relied, and continues to rely to a large 
extent, upon proceeds from sales of investments, rather than investment 
income, to defray a significant portion of its operating expenses.  Because 
such sales cannot be predicted with certainty, the Company attempts to 
maintain adequate working capital to provide for fiscal periods when there 
are no such sales. 

Realized Gains and Losses on Sales of Portfolio Securities:

  During the three years ended December 31, 1998, 1997 and 1996, the Company
sold various investments, realizing a net loss of $1,768,528, $3,199,502 and
$3,792,576, respectively.  During 1998, the Company realized losses on: the 
sale of its privately held investment in MultiTarget, Inc. of $209,999; 
publicly-held investments that were once privately held, including CORDEX 
Petroleums, Inc. in the amount of $357,736; Nanophase Technologies 
Corporation of  $329,055 (common stock shares purchased in the open market);
Princeton Video Image, Inc. of $288,369; and Voice Control Systems, Inc. 

                                   13

(which purchased the Company's investee company, PureSpeech, Inc.) of 
$724,826.  These losses were offset by a realized net gain of $141,457 in 
various publicly traded securities.  Net losses of $1,171,496 had been
recognized in prior years and realized in 1998.  Realizing losses and gains 
from prior years increases (for losses) or decreases (for gains) the 
Unrealized Appreciation on Investments.

    During 1997, the Company realized losses on the sale of its investments 
in: nFX Corporation in the amount of $2,631,720; Harber Brothers Productions,
Inc. of $1,205,000; Gel Sciences, Inc. of $633,028; Dynecology, Inc. of 
$99,900; and Micracor Corporation of $66,444.  These losses were offset by 
gains on the sales of Highline Capital Partners of $750,000 and of various 
publicly traded securities of $686,590. 

    During 1996, the Company realized a loss on the sale of its equity 
interest in Sonex International Corporation of $2,579,000.  However, because 
the investment had been written off in 1994, the loss did not affect 
earnings in 1996.  Also during 1996, the Company sold and realized a loss on
the sale of its equity interest in Micracor Corporation of $999,993 and net 
losses on sales of various publicly held securities of $213,583. 

Unrealized Appreciation and Depreciation of Portfolio Securities:

    The Board of Directors values the portfolio securities on a quarterly 
basis pursuant to the Company's Asset Valuation guidelines in accordance 
with the 1940 Act.  (See "Footnote to Schedule of Investments" contained in 
"Item 8. Financial Statements and Supplementary Data".)

    Net unrealized appreciation on investments before taxes increased by
$2,248,816 or 27.6% during the year ended December 31, 1998, from $8,158,732 
to $10,407,548.  The most significant increases in valuations during 1998 
were in NBX Corporation, $1,865,766; NeuroMetrix, Inc., $4,400,125; and PHZ 
Capital Partners, L.P., $443,432.  The most significant decrease during 1998 
was Nanophase Technologies Corporation, $5,508,466. Other changes included 
an increased valuation of Genomica Corporation, offset primarily by 
decreased valuations in MedLogic Global Corporation and Princeton Video 
Image, Inc. 

    Net unrealized appreciation on investments before taxes increased by
$1,491,143 or 22.4% during the year ended December 31, 1997, from $6,667,589 
to $8,158,732.  The most significant increases in valuations during 1997 were in
Nanophase Corporation, $3,775,701; NBX Corporation, $2,850,296; and PHZ 
Capital Partners, L.P., $405,622.  The most significant decreases were in 
Princeton Video Image, Inc., $1,563,605 and PureSpeech, Inc., $1,243,977 
(which was subsequently acquired by Voice Control Systems, Inc.).  

    Net unrealized appreciation on investments before taxes increased by
$4,564,996 or 217.1% during the year ended December 31, 1996, from $2,102,593 
to $6,667,589.  The most significant increases in valuations during 1996 
were in Gel Sciences, Inc., $1,127,500; Nanophase Technologies Corporation, 
$1,452,755; and Princeton Video Image, Inc., $751,000.  The most significant 
decrease was in the valuation of nFX Corporation, $1,892,240.

                                    14

Liquidity and Capital Resources

    The Company reported total cash, receivables and marketable securities 
(the primary measure of liquidity) at December 31, 1998 of $5,547,984 versus
$21,693,067 (net of $4,000,000 drawn from the J.P. Morgan line of credit) at
December 31, 1997 and $19,296,591 at December 31, 1996. 

    The decrease in cash, receivables and marketable securities from December 
31, 1997 to December 31, 1998 is mainly owing to: 1) the payment on May 12, 
1998 of a one-time cash dividend of $0.75 per share for a total of 
$8,019,728; 2) the decline in value of the Company's investment in Nanophase
Technologies Corporation of approximately $5.5 million and 3) the use of 
funds for 1998 cash operating expenses and realized losses.  

    Included in marketable securities as of December 31, 1998 were the 
Company's holdings in Nanophase Technologies Corporation of $1,211,249 and 
other publicly-held securities of $359,393.  Included in marketable 
securities as of December 31, 1997 were the Company's holdings in Nanophase 
Technologies Corporation of $6,854,660 and Princeton Video Image, Inc. of 
$1,064,895.  At December 31, 1997, both holdings were subject to lock-up 
agreements and were valued at discounts from market value: a 26 percent 
discount in the case of Nanophase Technologies Corporation and a 24 percent 
discount in the case of Princeton Video Image, Inc.  

    From 1997 to 1998, receivables from brokers increased by $380,707 or 100
percent, owing to transactions that settled in January 1999.  Note receivables
increased by $32,663 or 100 percent, as a result of the Company receipt of a 
note from the sale of its investment in one of its investee companies.  The 
Company's liabilities of accrued bonus and deferred income tax liability 
increased significantly during 1998.  Accrued bonus increased by $899,751 or 
112.3 percent to $1,323,559 as a result of the increase in the appreciation 
of investments.  The accrued bonus will not be paid out until the gains are 
realized.  Therefore, no bonuses were paid in 1998.  The deferred tax 
liability is also based on unrealized appreciation, and taxes will not be 
paid until the gains are realized.

    As of December 31, 1998, the Company had a $6,000,000 line of credit in 
place with J.P. Morgan, on which the Company had no outstanding balance.  
Management believes that its cash, receivables and marketable securities 
provide the Company with sufficient liquidity for its operations over the 
next 12 months. 

    On February 22, 1999, NBX Corporation announced that it had agreed to be
acquired by 3Com Corporation for approximately $90 million in cash plus 
additional consideration for employees of NBX.  This transaction was 
effective on March 5, 1999 and closed on March 8, 1999.  On closing, the 
Company received a total of $12,432,940 in cash, of which $1,475,276 was 
placed in a one-year escrow.  On February 23, 1999, the Board of Directors 
of the Company declared a cash dividend of $0.35 per share (approximately 
$3.7 million) to shareholders of record on March 19, 1999, payable on March 
25, 1999.  (See "Note 8 of Notes to Financial Statements" contained in "Item
8. Financial Statements and Supplementary Data".)

                                  15

Recent Developments -- Sub-Chapter M Status

    On September 25, 1997, the Company's Board of Directors approved a 
proposal to seek qualification of the Company as a RIC under Sub-Chapter M 
of the Code.  In order to qualify as a RIC, the Company must, in general (1)
annually derive at least 90 percent of its gross income from dividends, 
interest and gains from the sale of securities; (2) quarterly meet certain 
investment diversification requirements; and (3) annually distribute at 
least 90 percent of its investment company taxable income as a dividend.  
In addition to the requirement that the Company must annually distribute at 
least 90 percent of its investment company taxable income, the Company may 
either distribute or retain its taxable net capital gains from investments, 
but any net capital gains not distributed could be subject to corporate 
level tax.  Further, the Company could be subject to a four percent
excise tax (and in some cases, corporate level income tax) if it fails to
distribute 98 percent of its annual taxable income.

    Because of the specialized nature of its investment portfolio, the 
Company could satisfy the diversification requirements under Sub-Chapter M 
of the Code only if it received a certification from the SEC that it is 
"principally engaged in the furnishing of capital to other corporations 
which are principally engaged in the development or exploitation of 
inventions, technological improvements, new processes, or products not 
previously generally available."  

    On April 8, 1998, the Company announced that it had received such a
certification from the SEC for 1997.  Pursuant to the Company's receipt of 
the certification, the Company's Board of Directors declared and paid a one-
time cash dividend of $0.75 per share to meet one of the Company's 
requirements for qualification for Sub-Chapter M tax treatment.  On 
February 17, 1999, the Company received rulings from the IRS regarding other
issues relevant to the Company's tax status as a RIC.  (See "Note 6 of Notes
to Financial Statements" contained in "Item 8. Financial Statements and 
Supplementary Data".)  Although the SEC certification for 1997 was issued, 
there can be no assurance that the Company will receive such certification 
for 1998 or subsequent years (to the extent it needs additional 
certification as a result of changes in its portfolio) or that it will 
qualify as a RIC in 1999 or that, if it does qualify in 1999, it will 
continue to qualify in subsequent years. 
  
    The qualification of the Company as a RIC under Sub-Chapter M of the Code
depends on it satisfying certain technical requirements regarding its income,
investment portfolio, and distributions.  The Company was unable to satisfy 
these requirements for the 1998 tax year owing to the nature of the Company's
ownership interest in one of its investee companies.  In addition, because 
it realized taxable losses in 1998, it was not strategically advantageous 
for the Company to elect Sub-Chapter M tax status for 1998.  

    The Company changed the nature of its ownership interest in the non-
qualifying investee company effective January 1, 1999 in order to meet the 
Sub-Chapter M requirements.  However, there can be no assurance that the 
Company will qualify for Sub-Chapter M treatment for 1999 or subsequent 
years.  In addition, under certain circumstances, even if the Company were 
qualified for Sub-Chapter M treatment in 1999 and elected Sub-Chapter M 
treatment for that year, the Company might take action in a subsequent year 
to ensure that it would be taxed in that subsequent year as a C Corporation, 
rather than a RIC.

                                    16

    The Company incurred ordinary and capital losses during its C Corporation
taxable years that remain available for use and may be carried forward to its
1999 and subsequent taxable years.  Ordinarily, a corporation that elects to 
qualify as a RIC may not use its ordinary loss carryforwards from C 
Corporation taxable years to offset RIC investment company taxable income, 
although a RIC may in certain cases use capital loss carryforwards to reduce 
net capital gains.  In addition, a C Corporation that elects to qualify as a 
RIC and that makes an appropriate election continues to be taxable as a C 
Corporation on any gains realized within 10 years of its qualification as a 
RIC from sales of assets that were held by the corporation on the effective 
date of the election ("C Corporation Assets") to the extent of any gain 
built into the assets on such date ("Built-In Gain").  

    On February 17, 1999, the Company received a ruling from the IRS concluding
that the Company can carry forward its C Corporation losses to offset any 
Built-In Gains resulting from sales of its C Corporation Assets.  That 
ruling may enable the Company to retain some or all of the proceeds from 
such sales without disqualifying itself as a RIC or incurring corporate 
level income tax, depending on whether the Company's sale of C Corporation 
Assets with Built-In Gains will generate C Corporation E&P.  In general, a 
RIC is not permitted to have, as of the close of any RIC taxable year, E&P 
accumulated during any C Corporation taxable year. However, because the 
realization of Built-In Gains will occur while the Company is a RIC, a 
strong argument exists that, under current law and IRS pronouncements, the 
sale of C Corporation Assets with Built-In Gains during RIC taxable years 
will not generate C Corporation E&P.  The Company intends to use the $7.1 
million loss carryforward (which results in a tax credit of approximately 
$2.5 million) to reduce the taxes due to Built-In Gains.  The December 31, 
1998 NAV includes the utilization of the ordinary and capital loss 
carryforwards of approximately $0.23 per share.  The IRS recently announced 
an intention to issue formal guidance in 1999 concerning conversions of C 
Corporation to RICs.  Such guidance may include resolution of the E&P issue 
described above and other issues relevant to the Company.
  
    If necessary for liquidity purposes or to fund investment opportunities, 
in lieu of distributing its taxable net capital gains, the Company may 
retain such net capital gains and elect to be deemed to have made a 
distribution of the gains, or part thereof, to the shareholders under the 
"designated undistributed capital gain" rules of section 852(b)(3) of the 
Code.  In such a case, the Company would have to pay a 35 percent corporate 
level income tax on such "designated undistributed capital gain," but it 
would not have to distribute the excess of the retained "designated 
undistributed capital gain" over the amount of tax thereon in order to
maintain its RIC status.

Tax Consequences of Net Capital Gains

    The following simplified examples illustrate the tax treatment under Sub-
Chapter M of the Code for the Company and its shareholders with regard to 
three possible alternatives, assuming a net long-term capital gain of $1.00 
per share, consisting entirely of sales of non-real property assets held for
more than 12 months.

  Under Alternative A: 100 percent of net capital gain declared as a dividend
and distributed to shareholders:

                                    17

          1. No taxation at the Company level.

          2. Shareholders receive a $1.00 per share dividend and pay a 
maximum tax of 20 percent* or $.20 per share, retaining $.80 per share.

     Under Alternative B: 100 percent of net capital gain retained by the 
Company and designated as "undistributed capital gain" dividend:

          1. The Company pays a corporate level income tax of 35 percent on 
the undistributed gain or $.35 per share and retains 65 percent of the gain 
or $.65 per share.

          2. Shareholders increase their cost basis in their stock by $.65 
per share.  They pay a 20 percent* capital gains tax on 100 percent of the
undistributed gain of $1.00 per share or $.20 per share in tax.  Offsetting 
this tax, shareholders receive a tax credit equal to 35 percent of the 
undistributed gain or $.35 per share.

     Under Alternative C:  100 percent of net capital gain retained by the
Company, with no designated undistributed capital gain dividend:

          1. The Company pays a corporate level income tax of 35 percent on 
the retained gain or $.35 per share plus an excise tax of 4 percent of $.98 
per share, or about $.04 per share.

          2. There is no tax consequence at the shareholder level.

*Assumes all capital gains qualify for long-term rates of 20 percent.

Risk Factors

Investment in Small, Private Companies

     There are significant risks inherent in the Company's venture capital
business.  The Company has invested a substantial portion of its assets in 
private development stage or start-up companies.  These private businesses 
tend to be thinly capitalized, unproven, small companies that lack 
management depth and have not attained profitability or have no history of 
operations.  Because of the speculative nature and the lack of a public 
market for these investments, there is significantly greater risk of loss 
than is the case with traditional investment securities.  The Company 
expects that some of its venture capital investments will be a complete loss
or will be unprofitable and that some will appear to be likely to become 
successful but never realize their potential.  The Company has been risk
seeking rather than risk averse in its approach to venture capital and other
investments.  Neither the Company's investments nor an investment in the 
Company is intended to constitute a balanced investment program.  The 
Company has in the past relied and continues to rely to a large extent upon 
proceeds from sales of investments rather than investment income to defray a
significant portion of its operating expenses.

                                     18

Valuation of Portfolio Investments

     There is typically no public market of equity securities of the small 
private companies in which the Company invests.  As a result, the valuation 
of the equity securities in the Company's portfolio is subject to the good 
faith estimate of the Company's Board of Directors.  (See "Asset Valuation 
Policy Guidelines" in "Footnote to Schedule of Investments.")  In the 
absence of a readily ascertainable market value, the estimated value of the 
Company's portfolio of equity securities may differ significantly from the 
values that would be placed on the portfolio if a ready market for the 
equity securities existed.  Any changes in estimated net asset value are 
recorded in the Company's statement of operations as "Change in unrealized 
appreciation on investments."  (See "Management's Discussion and Analysis
of Financial Condition and Results of Operations.")

Illiquidity of Portfolio Investments

     Most of the investments of the Company are or will be equity securities
acquired directly   from small companies.  The Company's portfolio of equity
securities are and will usually be subject to restrictions on resale or 
otherwise have no established trading market.  The illiquidity of most of 
the Company's portfolio of equity securities may adversely affect the 
ability of the company to dispose of such securities at times when it may be
advantageous for the Company to liquidate such investments.

Fluctuations of Quarterly Results

     The Company's quarterly operating results could fluctuate as a result of
a number of factors.  These include, among others, variations in and the 
timing of the recognition of realized and unrealized gains or losses, the 
degree to which the Company encounters competition in its markets and 
general economic conditions.  As a result of these factors, results for any 
one quarter should not be relied upon as being indicative of performance in 
future quarters.  See "Management's Discussion and Analysis of Financial 
Condition and Results of Operations."

Risk of Loss of Pass Through Tax Treatment

     If the Company meets certain diversification and distribution requirements
under the Code, it may qualify as a RIC under the Code for pass-through tax
treatment.  The Company would cease to qualify for pass-through tax treatment
if it were unable to comply with these requirements, or if it ceased to 
qualify as a BDC under the 1940 Act.  The Company also could be subject to 
a four percent excise tax (and, in certain cases, corporate level income 
tax) if it failed to make certain distributions.  (See "Management's 
Discussion and Analysis of Financial Condition -- Recent Developments - 
Sub-Chapter M Status.")  The lack of Sub-Chapter M taxtreatment could have 
a material adverse effect on the total return, if any, obtainable from an 
investment in the Company.  If the Company fails to qualify as a RIC, the 
Company would become subject to federal income tax as if it were an
ordinary C Corporation, which would result in a substantial reduction in the
Company's net assets and the amount of income available for distribution to 
the Company's stockholders.

                                      19

Risks Relating to the Year 2000 Issue

     The "Year 2000" computer problem has arisen because many computer
applications worldwide will not properly recognize the date change from 
December 31, 1999, to January 1, 2000.  The computer applications may 
revert to 1900 or some other date because of the way in which dates were 
encoded and calculated, potentially causing production of erroneous data, 
miscalculations, system failures and other operational problems.

     The Company has undertaken the evaluation of the Year 2000 impact on its
critical computer hardware and software.  The Company has not incurred, nor 
does it anticipate that it will incur, any material cost in addressing its 
Year 2000 problem.  The Company is developing a strategic plan focusing on 
achieving Year 2000 compliance.  Certain systems are being replaced and or 
modified to be Year 2000 compliant.  At the present time, it is not possible 
to determine whether any such events are likely to occur or to quantify any 
potential negative impact they may have on the Company's future results of 
operations and financial condition.

     Ultimately, the potential impact of the Year 2000 issue will depend not
only on the success of the corrective measures undertaken by the Company, 
but also on the way in which the Year 2000 issue is addressed by vendors, 
service providers, counterparties, utilities, governmental agencies and 
other entities with which the Company does business. 

Forward-Looking Statements

     The information contained herein contains certain forward-looking 
statements.  These statements include the plans and objectives of management
for future operations and financial objectives, portfolio growth and 
availability of funds.  These forward-looking statements are subject to the 
inherent uncertainties in predicting future results and conditions.  Certain 
factors that could cause actual results and conditions to differ materially 
from those projected in these forward-looking statements are set forth 
herein.  Other factors that could cause actual results to differ materially 
include the uncertainties of economic, competitive and market conditions, 
and future business decisions, all of which are difficult or impossible to 
predict accurately and many of which are beyond the control of the Company.
Although the Company believes that the assumptions underlying the forward-
looking statements included herein are reasonable, any of the assumptions
could be inaccurate and therefore there can be no assurance that the forward-
looking statements included or incorporated by reference herein will prove to 
be accurate.  Therefore, the inclusion of such information should not be 
regarded as a representation by the Company or any other person that the 
objectives and plans of the Company will be achieved.
      
Item 7a.  Quantitative and Qualitative Disclosures About Market Risk

     The Company does not hold any derivatives.

                                    20

Item 8.   Financial Statements and Supplementary Data



                         HARRIS & HARRIS GROUP, INC.
                INDEX TO FINANCIAL STATEMENTS AND SCHEDULES


     The following reports and financial schedules of Harris & Harris Group,
Inc. are filed herewith and included in response to Item 8.

Documents                                                             Page    
     Report of Independent Public Accountants. . . . . . . . . . .     22

Financial Statements

     Statements of Assets and Liabilities 
          as of December 31, 1998 and 1997 . . . . . . . . . . . .     23
      
     Statements of Operations for the 
          years ended December 31, 1998, 1997 and 1996 . . . . . .     24
     
     Statements of Cash Flows for the
         years ended December 31, 1998, 1997 and 1996. . . . . . .     25
     
     Statements of Changes in Net Assets for the
         years ended December 31, 1998, 1997 and 1996. . . . . . .     26
     
     Schedule of Investments as of December 31, 1998 . . . . . . .  27-30

     Footnote to Schedule of Investments . . . . . . . . . . . . .  31-33
            
     Notes to Financial Statements . . . . . . . . . . . . . . . .  34-40

     Selected Per Share Data and Ratios for the
         years ended December 31, 1998, 1997, 1996, 1995 and 1994.     41

     Schedules other than those listed above have been omitted because they 
are not applicable or the required information is presented in the financial
statements and/or related notes.

                                    21

                   REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS

     
To Harris & Harris Group, Inc.:

     We have audited the accompanying statements of assets and liabilities of
Harris & Harris Group, Inc. (a New York corporation) as of December 31, 1998 
and 1997, including the schedule of investments as of December 31, 1998, and 
the related statements of operations,  cash flows and changes in net assets 
for the three years ended December 31, 1998, and the selected per share data
and ratios for each of the five years ended December 31, 1998.  These 
financial statements and selected per share data and ratios are the 
responsibility of the Company's management.  Our responsibility is to 
express an opinion on these financial statements and selected per share 
data and ratios based on our audits.

     We conducted our audits in accordance with generally accepted auditing
standards.  Those standards require that we plan and perform the audit to 
obtain reasonable assurance about whether the financial statements and 
selected per share data and ratios are free of material misstatement.  An 
audit includes examining, on a test basis, evidence supporting the amounts 
and disclosures in the financial statements.  Our procedures included 
confirmation of securities owned as of December 31, 1998 and 1997, by 
correspondence with the custodian and brokers.  An audit also includes 
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement 
presentation.  We believe that our audits provide a reasonable basis for 
our opinion.

     As explained in Note 2, the financial statements include securities 
valued at $19,562,386  (86.7 percent of net assets), whose values have been 
estimated by the Board of Directors in the absence of readily ascertainable 
market values.  However, because of the inherent uncertainty of valuation, 
those estimated values may differ significantly from the values that would 
have been used had a ready market for the securities existed, and the 
differences could be material.

   In our opinion, the financial statements and selected per share data and 
ratios referred to above present fairly, in all material respects, the 
financial position of Harris & Harris Group, Inc. as of December 31, 1998 
and 1997, the results of its operations, its cash flows and the changes in 
its net assets for the three years ended December 31, 1998, and the 
selected per share data and ratios for each of the five years ended 
December 31, 1998 in conformity with generally accepted accounting principles.

                                           
                                           /s/  Arthur Andersen LLP
New York, New York
February 10, 1999
                                  22    

<TABLE>
<CAPTION>
                 STATEMENTS OF ASSETS AND LIABILITIES

                                    
                                 ASSETS
<S>                                       <C>               <C>
                                         December 31, 1998  December 31, 1997
                                                              
Investments, at value (See accompanying schedule of 
   investments and notes). . . . . . . . . $    24,532,191  $  38,659,230
Cash and cash equivalents. . . . . . . . .         164,143        145,588
Receivable from brokers. . . . . . . . . .         380,707              0
Interest receivable. . . . . . . . . . . .             666        111,106
Prepaid expenses . . . . . . . . . . . . .          90,649         85,126
Note receivable. . . . . . . . . . . . . .          32,663              0
Other assets . . . . . . . . . . . . . . .         157,840        272,734
                                           ---------------  -------------
Total assets . . . . . . . . . . . . . . . $    25,358,859  $  39,273,784
                                           ===============  =============
                         LIABILITIES & NET ASSETS

Accounts payable and accrued liabilities   $       505,118  $     475,683
Accrued bonus (Note 3) . . . . . . . . . .       1,323,559        423,808
Deferred rent. . . . . . . . . . . . . . .          42,409         51,662
Deferred income tax liability (Note 6) . .         931,064        667,697
Demand Promissory Note Payable (Note 7). .               0      4,000,000
                                            --------------   ------------
Total liabilities. . . . . . . . . . . . .       2,802,150      5,618,850
                                            --------------   ------------
Commitments and contingencies (Notes 7 and 8)

Net assets . . . . . . . . . . . . . . . .  $   22,556,709  $  33,654,934
                                            ==============  =============
Net assets are comprised of:
Preferred stock, $0.10 par value, 
   2,000,000 shares authorized; 
   none issued. . . . . . . . . . . . . . . $            0  $           0
Common stock, $0.01 par value, 25,000,000 
   shares authorized; 10,692,971 issued 
   at 12/31/98 and issued and outstanding 
   at 12/31/97 . . . . . . . . . . . . . . .       106,930        106,930
Additional paid in capital . . . . . . . . .    16,158,381     16,178,979
Accumulated net realized (loss) income . . .      (525,177)    12,028,191
Accumulated unrealized appreciation of 
   investments, net of deferred tax 
   liability of $3,410,884 at 12/31/98
   and $2,817,898 at 12/31/97 . . . . . . . .    6,996,664      5,340,834
Treasury stock, at cost (101,739 shares)  . .     (180,089)             0
                                             -------------  -------------
Net assets. . . . . . . . . . . . . . . . . .$  22,556,709  $  33,654,934
                                             =============  =============
Shares outstanding  . . . . . . . . . . . . .   10,591,232     10,692,971
                                             -------------  -------------
Net asset value per outstanding share . . . .$        2.13  $        3.15
                                             =============  =============
</TABLE>
  The accompanying notes are an integral part of these financial statements.

                                    23
<TABLE>
<CAPTION>
                         STATEMENTS OF OPERATIONS

<S>                                 <C>          <C>          <C>
                                    Year Ended   Year Ended   Year Ended
                                     12/31/98     12/31/97     12/31/96
Investment income:
 Interest from:
  Fixed-income securities  . . . . $   355,591 $    490,807  $  803,819
  Affiliated companies . . . . . .     124,877       40,000      40,779
 Dividend income--
   unaffiliated companies. . . . .       2,550            0       8,024
 Dividend income--
   affiliated companies. . . . . .      50,000       52,500           0
 Consulting and 
   administrative fees . . . . . .           0       29,870      68,185
 Other income  . . . . . . . . . .     102,468          869      92,610
                                    ----------- -----------  ----------
  Total investment income. . . . .     635,486      614,046   1,013,417

Expenses:
  Salaries and benefits. . . . . .     831,121    1,507,257   1,524,826
  Bonus accrual (Note 3) . . . . .     899,751      423,808           0
  Administration and operations. .     330,879      392,114     474,537
  Professional fees. . . . . . . .     411,480      327,038     675,241
  Depreciation . . . . . . . . . .      47,936       48,968      57,426
  Rent . . . . . . . . . . . . . .     159,515      130,092     160,601
  Directors' fees and expenses . .     129,253      100,496      80,702
  Custodian fees . . . . . . . . .      10,513       15,517      11,983
  Restructuring charges. . . . . .           0      100,000           0
  Other expense (Note 7) . . . . .     728,862            0           0
  Interest expense . . . . . . . .      85,476            0           0
                                    -----------  ----------- -----------
    Total expenses . . . . . . . .   3,634,786    3,045,290   2,985,316
                                    -----------  ----------- -----------
  Operating loss 
    before income taxes  . . . . .  (2,999,300)  (2,431,244) (1,971,899)
  Income tax benefit (Note 6). . .     234,188      933,103     680,834
                                    ----------- ------------ -----------
Net operating loss . . . . . . . .  (2,765,112)  (1,498,141) (1,291,065)

Net realized loss on investments:
  Realized loss on 
    sale of investments  . . . . .  (1,768,528)  (3,199,502) (3,792,576)
                                    ----------- -----------  -----------
    Total realized loss. . . . . .  (1,768,528)  (3,199,502) (3,792,576)
  Income tax benefit (Note 6). . .           0    1,119,825   1,327,401
                                    ----------- -----------  -----------
  Net realized loss on investments  (1,768,528)  (2,079,677) (2,465,175)
                                    ----------- -----------  -----------
Net realized loss. . . . . . . . .  (4,533,640)  (3,577,818) (3,756,240)

Net increase in unrealized 
    appreciation on investments:
  Increase as a result of 
    investment sales . . . . . . .   2,135,176       93,999   2,525,548
  Decrease as a result of 
    investment sales . . . . . . .    (963,680)  (2,892,408)          0
  Increase on investments held . .   9,766,320    7,297,164   4,112,413
  Decrease on investments held . .  (8,689,000)  (3,007,612) (2,072,965)
                                   ------------ ------------ -----------
    Change in unrealized appreciation 
    on investments . . . . . . . .   2,248,816    1,491,143   4,564,996
  Income tax provision (Note 6). .    (592,986)    (521,900) (1,597,748)
                                   ------------  ----------- -----------
  Net increase in unrealized appreciation
    on investments . . . . . . . .   1,655,830      969,243   2,967,248
                                   ------------  -----------  ----------
Net decrease in net assets 
  resulting from operations:
  Total. . . . . . . . . . . . . . $(2,877,810) $(2,608,575) $ (788,992)
                                   ============ ============ ===========
  Per outstanding share. . . . . . $     (0.27) $     (0.24) $    (0.08)
                                   ============ ============ ===========
</TABLE>
 The accompanying notes are an integral part of these financial statements.

                                    24

<TABLE>
<CAPTION>
                         STATEMENTS OF CASH FLOWS

<S>                                 <C>           <C>           <C>          
                                    Year Ended    Year Ended    Year Ended
                                     12/31/98      12/31/97      12/31/96
Cash flows (used in) provided 
 by operating activities:
Net decrease in net assets 
 resulting from operations . . . $  (2,877,810) $ (2,608,575) $ (788,992)
Adjustments to reconcile net decrease in net assets
resulting from operations to net cash (used in) 
provided by operating activities:
 Net realized and unrealized (gain) loss
   on investments. . . . . . . .      (480,288)    1,708,359    (772,420)
 Deferred income taxes . . . . .       263,367    (1,442,094)  1,636,817
 Depreciation. . . . . . . . . .        47,936        48,968      57,426
 Other . . . . . . . . . . . . .        (2,927)            0     (10,144)
Changes in assets and liabilities:
 Receivable from brokers . . . .      (380,707)            0     205,789
 Prepaid expenses. . . . . . . .        (5,523)       (3,625)      5,475
 Interest receivable . . . . . .       110,440        87,236     102,376
 Taxes receivable. . . . . . . .             0     2,119,492  (1,679,377)
 Notes receivable. . . . . . . .       (32,663)            0           0
 Other assets. . . . . . . . . .        86,312        40,296    (103,981)
 Accounts payable 
  and accrued liabilities. . . .        81,235        49,555      22,197
 Accrued bonus . . . . . . . . .       899,751       423,808           0
 Deferred rent . . . . . . . . .        (9,253)       (9,252)     10,279
 Collection on notes receivable.       800,000             0           0
 Purchase of fixed assets. . . .       (16,426)      (10,169)    (35,777)
                                    -----------   ----------- ----------- 
 Net cash (used in) provided 
  by operating activities. . . .    (1,516,556)      403,999  (1,350,332)

Cash provided by (used in) investing activities:
 Net sale (purchase) of short-term 
  investments and 
  marketable securities. . . . .    14,715,834      (155,667)  6,035,532
 Investment in 
  private placements and loans .      (960,308)   (4,511,434) (4,981,614)
                                    -----------   ----------- -----------
 Net cash provided by 
  (used in) investing activities     13,755,526   (4,667,101)  1,053,918

Cash flows (used in) provided 
  by financing activities:
 Payment of dividend . . . . . .     (8,019,728)           0           0
 Purchase of treasury stock (Note 4)   (254,786)           0           0
 Proceeds from exercise 
  of stock options (Note 3). . .              0      253,250      87,500
 Proceeds (payment of)
  from note payable (Note 7) . .     (4,000,000)   4,000,000           0
 Proceeds from sale of 
  stock (Note 4) . . . . . . . .         54,099            0           0
                                    ------------  ----------- -----------
 Net cash (used in) provided 
  by financing activities. . . .    (12,220,415)   4,253,250      87,500

Net increase (decrease) 
 in cash and cash equivalents:
 Cash and cash equivalents 
  at beginning of the year. . . .       145,588      155,440     364,354
 Cash and cash equivalents 
  at end of the year. . . . . . .       164,143      145,588     155,440
                                    ------------  ------------ ----------
 Net increase (decrease) in cash and
 cash equivalents . . . . . . . .   $    18,555   $   (9,852) $ (208,914)
                                    ============  =========== ===========
Supplemental disclosures of cash flow information:
 Income taxes paid. . . . . . . .   $       372   $     5,909 $   57,234
 Interest paid. . . . . . . . . .   $    85,378   $         0 $        0

</TABLE>
  The accompanying notes are an integral part of these financial statements.

                                  25

<TABLE>
<CAPTION>
                        STATEMENTS OF CHANGES IN NET ASSETS 

<S>                                  <C>           <C>           <C>
                                     Year Ended    Year Ended    Year Ended
                                      12/31/98      12/31/97      12/31/96
        
Changes in net assets from operations:

  Net operating loss. . . . . . . .$(2,765,112)  $(1,498,141)  $(1,291,065)
  Net realized loss on investments. (1,768,528)   (2,079,677)   (2,465,175)
  Net increase (decrease) in unrealized
    appreciation on investments
    as a result of sales  . . . . .  1,171,496    (1,818,966)    1,641,606
  Net increase in unrealized 
     appreciation on 
     investments held . . . . . . .    484,334     2,788,209     1,325,642
                                   ------------  ------------  ------------ 
  Net decrease in net assets 
    resulting from operations . . . (2,877,810)   (2,608,575)     (788,992)

Changes in net assets from 
     capital stock transactions:

   Payment of dividend. . . . . . . (8,019,728)            0             0
   Purchase of treasury stock . . .   (254,786)            0             0
   Proceeds from exercise of
     stock options and warrants . .          0       253,250        87,500
   Proceeds from sale of stock. . .     54,099             0             0
   Tax benefit of 
    restricted stock award 
    and common stock transactions .          0        77,656        72,186
                                   ------------    ----------   -----------
   Net (decrease) increase in 
     net assets resulting from 
     capital stock transactions . . (8,220,415)      330,906       159,686
                                   ------------    ----------   -----------
   
Net decrease in net assets  . . . .(11,098,225)   (2,277,669)     (629,306)

Net assets:

  Beginning of the year . . . . . . 33,654,934    35,932,603    36,561,909
                                   -----------   -----------   -----------
  End of the year . . . . . . . . .$22,556,709   $33,654,934   $35,932,603
                                   ===========   ===========   ===========
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                   26

<TABLE>
<CAPTION>
                       SCHEDULE OF INVESTMENTS DECEMBER 31, 1998

<S>                                    <C>            <C>           <C>
                                       Method of       Shares/
                                       Valuation (3)  Principal     Value

 Investments in Unaffiliated Companies (10)(11)(12) -- 
  12.0% of total investments

 Publicly Traded Portfolio (Common stock unless noted otherwise) --
  6.4% of total investments
 
 Somnus Medical Technology, Inc. (1)(4) --
  Biotechnology and Healthcare related . .(C)         47,200     $  141,600

 Nanophase Technologies Corporation (1)(6) --
  Manufactures and markets inorganic crystals of 
  nanometric dimensions -- 
  4.59% of fully diluted equity
  Common Stock . . . . . . . . . . . . . .(C)        672,916      1,211,249

 Princeton Video Image, Inc. (1) -- Real time 
  sports and entertainment advertising -- 
  0.59% of fully diluted equity  . . . . .(C)         62,600        178,410

 Voice Control Systems, Inc. (1)(2) -- Supplier 
   of speech recognition and 
   related speech input technology . . . .(C)         22,964         39,383
                                                                 ----------
Total Publicly Traded Portfolio (cost: $1,414,202). . . . . . .  $1,570,642
                                                                 ----------

Private Placement Portfolio (Illiquid) -- 5.6% of total investments

 Exponential Business Development Company (1)(2)(5) --
  Venture capital partnership focused on early stage companies
  Limited partnership interest . . . . . .(A)           --       $   25,000

 MedLogic Global Corporation (1)(2) -- Medical cyanoacrylate
  adhesive -- 0.40% of fully diluted equity
  Series B Convertible Preferred Stock . .(B)         60,319
  Common Stock . . . . . . . . . . . . . .(B)         25,798        565,978

 SciQuest, Inc. (1)(2)(6)(9) -- Internet e-commerce source for
  scientific products -- 3.61% of fully diluted equity
  Series C Convertible Preferred Stock . .(A)        277,163         
  Warrants at $2.7962 expiring 6/30/07 . .(A)         26,822        775,000
                                                                 ----------
Total Private Placement Portfolio (cost: $1,833,774). . . . . .  $1,365,978
                                                                 ----------
Total Investments in 
 Unaffiliated Companies (cost: $3,247,976)  . . . . . . . . . .  $2,936,620
                                                                 ----------
</TABLE>
    The accompanying notes are an integral part of this schedule.
                                      
                                     27

<TABLE>
<CAPTION>
              SCHEDULE OF INVESTMENTS DECEMBER 31, 1998

<S>                                    <C>          <C>            <C>
                                       Method of     Shares/
                                       Valuation(3) Principal      Value

Private Placement Portfolio (Illiquid) in Non-Controlled 
Affiliates (10)(12) -- 49.9% of total investments

 Genomica Corporation (1)(2)(6)(7) -- Develops software
  that enables the study of complex genetic diseases -- 
  7.05% of fully diluted equity 
  Common Stock . . . . . . . . . . . . . (B)         199,800
  Series A Voting 
   Convertible Preferred Stock . . . . . (B)       1,660,200    $1,209,730

 InSite Marketing Technology, Inc. (1)(2)(4) -- Integrates
  marketing science and sales strategy into e-commerce
  -- 7.12% of fully diluted equity
  Common Stock . . . . . . . . . . . . . (A)       1,351,351       500,000

 NBX Corporation (1)(2)(6) -- Exploits innovative 
  distributed computing technology for use in small business
  telephone systems -- 13.95% of fully diluted equity
  Promissory Note -- 
   8% due March 16, 2001 . . . . . . . . (A)      $   10,000
  Series A Convertible Preferred Stock . (B)         500,000               
  Series C Convertible Preferred Stock . (B)         240,793                  
  Series D Convertible Preferred Stock . (B)          59,965     6,416,064

 PHZ Capital Partners Limited Partnership (2) -- Organizes 
  and manages investment partnerships -- 20.0% of fully 
  diluted equity 
  Limited partnership interest . . . . . (D)           --        1,849,054

 Questech Corporation (1)(2)(6) -- Manufactures and 
  markets proprietary decorative tiles and signs -- 12.40% of 
  fully diluted equity
  Common Stock  . . . . . . . . . . . . .(D)         565,792     2,263,168
  Warrants at $4.00 expiring 11/28/01 . .(A)         166,667           167
                                                               -----------
Private Placement Portfolio 
  in Non-Controlled Affiliates (cost: $5,920,308) . . . . . .  $12,238,183
                                                               -----------
</TABLE>
      The accompanying notes are an integral part of this schedule.

                                 28

<TABLE>
<CAPTION>
                   SCHEDULE OF INVESTMENTS DECEMBER 31, 1998

<S>                                      <C>             <C>           <C>
                                         Method of        Shares/
                                         Valuation (3)   Principal     Value

Private Placement Portfolio in Controlled Affiliates (10)(12) 
(Illiquid) -- 24.3% of total investments

 NeuroMetrix, Inc. (1)(2)(6)(8) -- Developing devices for: 1) diabetics 
  to monitor their blood glucose and 2) detection of carpal tunnel 
  syndrome -- 27.67% of fully diluted equity
   Series A Convertible Preferred Stock . . .(B)         175,000
   Series B Convertible Preferred Stock . . .(B)         125,000 
   Series C-2 Convertible Preferred Stock . .(B)         229,620  $ 5,958,225
                                                                  -----------
Total Private Placement Portfolio 
  in Controlled Affiliates (cost: $1,558,100). . . . . . . . . .  $ 5,958,225
                                                                  -----------
U.S. Government Obligations -- 13.8% of total investments
  
 U.S. Treasury Bill dated 02/05/98 due date
   02/04/99 -- 4.4% yield . . . . . . . . . .(K)      $  300,000 $    298,878
 U.S. Treasury Bill dated 02/05/98 due date
   02/04/99 -- 4.4% yield . . . . . . . . . .(K)      $  600,000      597,756
 U.S. Treasury Bill dated 08/13/98 due date
   02/11/99 -- 4.3% yield . . . . . . . . . .(K)      $  400,000      398,160
 U.S. Treasury Bill dated 03/05/98 due date
   03/04/99 -- 4.3% yield . . . . . . . . . .(K)     $ 1,550,000    1,538,902
 U.S. Treasury Bill dated 11/19/98 due date
   05/20/99 -- 4.5% yield . . . . . . . . . .(K)      $  575,000      565,467
                                                                -------------
Total Investments in U.S. Government Obligations
 (cost: $3,398,259). . . . . . . . . . . . . . . . . . . . .    $   3,399,163
                                                                -------------
Total Investments -- 100% (cost: $14,124,643). . . . . . . .    $  24,532,191
                                                                =============
</TABLE>
       The accompanying notes are an integral part of this schedule.

                                      29

                  SCHEDULE OF INVESTMENTS DECEMBER 31, 1998


Notes to Schedule of Investments

(1) Represents a non-income producing security.  Equity investments that have
    not paid dividends within the last twelve months are considered to be 
    non-income producing.
(2) Legal restrictions on sale of investment.
(3) See Footnote to Schedule of Investments for a description of the Method 
    of Valuation A to L.
(4) These investments were made during 1998.  Accordingly, the amounts shown 
    on the schedule represent the gross additions in 1998.
(5) No changes in valuation occurred in these investments during the year 
    ended December 31, 1998.
(6) These investments are development stage companies.  A development stage
    company is defined as a company that is devoting substantially all of its
    efforts to establishing a new business, and either has not yet commenced 
    its planned principal operations or has commenced such operations but has 
    not realized significant revenue from them.
(7) Genomica Corporation was cofounded by the Company, Cold Spring Harbor 
    Laboratory and Falcon Technology Partners, LP. Mr. G. Morgan Browne 
    serves on the Board of Directors of the Company and is Administrative 
    Director of  Cold Spring Harbor Laboratory.
(8) The percentage owned by the Company proforma for the January 21, 1999
    financing is 18.04%.
(9) SciQuest, Inc. acquired BioSupplyNet, Inc.
(10)Investments in unaffiliated companies consist of investments where Harris &
    Harris Group, Inc. (the "Company") owns less than 5 percent of the 
    investee company. Investments in non-controlled affiliated companies 
    consist of investments where the Company owns more than 5 percent but 
    less than 25 percent of the investee company. Investments in controlled
    affiliated companies consist of investments where the Company owns more
    than 25 percent of the investee company.
(11)The aggregate cost for federal income tax purposes of investments in
    unaffiliated companies is $3,247,976.  The gross unrealized appreciation 
    based on tax cost for these securities is $156,440.  The gross unrealized
    depreciation on the cost for these securities is $467,796.
(12)The percentage ownership of each investee disclosed in the Schedule of
    Investments expresses the potential common equity interest in each such 
    investee.  The calculated percentage represents the amount of issuer's 
    common stock the Company owns or can acquire as a percentage of the 
    issuer's total outstanding common stock plus common shares reserved for
    issued and outstanding warrants, convertible securities and 
    stock options.

        The accompanying notes are an integral part of this schedule.

                                   30
        

                     FOOTNOTE TO SCHEDULE OF INVESTMENTS


ASSET VALUATION POLICY GUIDELINES

   The Company's investments can be classified into five broad categories for
valuation purposes:

     1) EQUITY-RELATED SECURITIES

     2) INVESTMENTS IN INTELLECTUAL PROPERTY OR PATENTS OR RESEARCH AND
        DEVELOPMENT IN TECHNOLOGY OR PRODUCT DEVELOPMENT

     3) LONG-TERM FIXED-INCOME SECURITIES
     4) SHORT-TERM FIXED-INCOME INVESTMENTS
     5) ALL OTHER INVESTMENTS

     The Investment Company Act of 1940 (the "1940 Act") requires periodic
valuation of each investment in the Company's portfolio to determine net asset
value. Under the 1940 Act, unrestricted securities with readily available 
market quotations are to be valued at the current market value; all other 
assets must be valued at "fair value" as determined in good faith by or 
under the direction of the Board of Directors.

     The Company's Board of Directors is responsible for 1) determining overall
valuation guidelines and 2) ensuring the valuation of investments within the
prescribed guidelines.

     The Company's Investment and Valuation Committee, comprised of at least
three or more Board members, is responsible for reviewing and approving the
valuation of the Company's assets within the guidelines established by the 
Board of Directors.

     Fair value is generally defined as the amount that an investment could 
be sold for in an orderly disposition over a reasonable time.  Generally, to
increase objectivity in valuing the assets of the Company, external measures
of value, such as public markets or third-party transactions, are utilized 
whenever possible. Valuation is not based on long-term work-out value, nor 
immediate liquidation value, nor incremental value for potential changes 
that may take place in the future.

     Valuation assumes that, in the ordinary course of its business, the 
Company will eventually sell its investment.

     The Company's valuation policy with respect to the five broad investment
categories is as follows:


EQUITY-RELATED SECURITIES

     Equity-related securities are carried at fair value using one or more of
the following basic methods of valuation:

   A.  Cost:  The cost method is based on the original cost to the Company. 
This method is generally used in the early stages of a company's development
until significant positive or negative events occur subsequent to the date
of the original investment that dictate a change to another valuation 
method. Some examples of such events are: 1) a major recapitalization; 2) 
a major refinancing; 3) a significant third-party transaction; 4) the 
development of a meaningful public market for the company's common stock; 
5) significant positive or negative changes in the company's business.

                                     31

   B.  Private Market:  The private market method uses actual third-party
transactions in the company's securities as a basis for valuation, using actual,
executed, historical transactions in the company's securities by responsible
third parties.  The private market method may also use, where applicable,
unconditional firm offers by responsible third parties as a basis for valuation.

   C.  Public Market:   The public market method is used when there is an
established public market for the class of the company's securities held by 
the Company.  The Company discounts market value for securities that are 
subject to significant legal, contractual or practical restrictions, 
including large blocks in relation to trading volume.  Other securities, for
which market quotations are readily available, are carried at market value 
as of the time of valuation.

     Market value for securities traded on securities exchanges or on the
Nasdaq National Market is the last reported sales price on the day of 
valuation.  For other securities traded in the over-the-counter market and 
listed securities for which no sale was reported on that day, market value 
is the mean of the closing bid price and asked price on that day.

     This method is the preferred method of valuation when there is an
established public market for a company's securities, as that market 
provides the most objective basis for valuation.

   D.  Analytical Method:  The analytical method is generally used to value 
an investment position when there is no established public or private market
in the company's securities or when the factual information available to the
Company dictates that an investment should no longer be valued under either 
the cost or private market method. This valuation method is inherently 
imprecise and ultimately the result of reconciling the judgments of the 
Company's Investment and Valuation Committee members, based on the data 
available to them. The resulting valuation, although stated as a precise 
number, is necessarily within a range of values that vary depending upon 
the significance attributed to the various factors being considered. Some 
of the factors considered may include the financial condition and operating 
results of the company, the long-term potential of the business of the 
company, the values of similar securities issued by companies in similar 
businesses, the proportion of the company's securities owned by the Company 
and the nature of any rights to require the company to register restricted 
securities under applicable securities laws.

INVESTMENTS IN INTELLECTUAL PROPERTY OR PATENTS OR RESEARCH AND DEVELOPMENT 
IN TECHNOLOGY OR PRODUCT DEVELOPMENT

  Such investments are carried at fair value using the following basic methods
of valuation:

  E.  Cost:  The cost method is based on the original cost to the Company. 
Such method is generally used in the early stages of commercializing or 
developing intellectual property or patents or research and development in 
technology or product development until significant positive or adverse 
events occur subsequent to the date of the original investment that dictate 
a change to another valuation method.

  F.  Private Market:  The private market method uses actual third-party
investments in intellectual property or patents or research and development 
in technology or product development as a basis for valuation, using actual 
executed historical transactions by responsible third parties.  The private 
market method may also use, where applicable, unconditional firm offers by 
responsible third parties as a basis for valuation.

                                     32

  G.  Analytical Method:  The analytical method is used to value an investment
after analysis of the best available outside information where the factual
information available to the Company dictates that an investment should no 
longer be valued under either the cost or private market method. This 
valuation method is inherently imprecise and ultimately the result of 
reconciling the judgments of the Company's Investment and Valuation 
Committee members. The resulting valuation, although stated as a precise 
number, is necessarily within a range of values that vary depending upon 
the significance attributed to the various factors being considered. Some 
of the factors considered may include the results of research and 
development, product development progress, commercial prospects, term of 
patent and projected markets.


LONG-TERM FIXED-INCOME SECURITIES

  H.  Fixed-Income Securities for which market quotations are readily 
available are carried at market value as of the time of valuation using the 
most recent bid quotations when available.

  Securities for which market quotations are not readily available are carried
at fair value using one or more of the following basic methods of valuation:

  I.  Fixed-Income Securities  are valued by independent pricing services 
that provide market quotations based primarily on quotations from dealers 
and brokers, market transactions, and other sources.

  J.  Other Fixed-Income Securities that are not readily marketable are valued
at fair value by the Investment and Valuation Committee.

SHORT-TERM FIXED-INCOME INVESTMENTS

  K.  Short-Term Fixed-Income Investments are valued at market value at the 
time of valuation.  Short-term debt with remaining maturity of 60 days or 
less is valued at amortized cost.


ALL OTHER INVESTMENTS

  L.  All Other Investments are reported at fair value as determined in good
faith by the Investment and Valuation Committee.

  The reported values of securities for which market quotations are not 
readily available and for other assets reflect the Investment and Valuation 
Committee's judgment of fair values as of the valuation date using the 
outlined basic methods of valuation.  They do not necessarily represent an 
amount of money that would be realized if the securities had to be sold in 
an immediate liquidation.  The Company makes many of its portfolio 
investments with the view of holding them for a number of years, and the 
reported value of such investments may be considered in terms of disposition
over a period of time. Thus valuations as of any particular date are not 
necessarily indicative of amounts that may ultimately be realized as a 
result of future sales or other dispositions of investments held.

                                     33

NOTES TO FINANCIAL STATEMENTS


NOTE 1.  THE COMPANY

     Harris & Harris Group, Inc. (the "Company") is a venture capital 
investment company operating as a business development company ("BDC") under
the Investment Company Act of 1940 ("1940 Act").  A BDC is a specialized 
type of investment company under the 1940 Act.  The Company operates as an 
internally managed investment company whereby its officers and employees, 
under the general supervision of its Board of Directors, conduct its 
operations.

     The Company elected to become a BDC on July 26, 1995, after receiving the
necessary approvals.  From September 30, 1992 until the election of BDC 
status, the Company operated as a closed-end, non-diversified, investment 
company under the 1940 Act.  Upon commencement of operations as an investment
company, the Company revalued all of its assets and liabilities at fair value
as defined in the 1940 Act.  Prior to such time, the Company was registered 
and filed under the reporting requirements of the Securities and Exchange 
Act of 1934 as an operating company and, while an operating company, operated
directly and through subsidiaries.

     On September 25, 1997, the Company's Board of Directors approved a 
proposal to seek qualification as a Regulated Investment Company ("RIC") 
under Sub-Chapter M of the Internal Revenue Code.  As a RIC, the Company 
must, among other things, distribute at least 90 percent of its taxable net 
income and may either distribute or retain its taxable net realized capital 
gains on investments.  (See "Item 7. Management's Discussion and Analysis of
Financial Condition and Results of Operations - Recent Developments.")  
There can be no assurance that the Company will qualify as a RIC or that if 
it does qualify, it will continue to qualify.  In addition, even if the 
Company were to qualify as a RIC, and elected Sub-Chapter M treatment for 
that year, the Company might take action in a subsequent year to ensure that 
it would be taxed in that subsequent year as a C Corporation, rather than 
a RIC.

NOTE 2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     The following is a summary of significant accounting policies followed 
in the preparation of the financial statements:

     Cash and Cash Equivalents.  Cash and cash equivalents include money 
market instruments with maturities of less than three months.

     Portfolio Investment Valuations.  Investments are stated at "fair value" 
as defined in the 1940 Act and in the applicable regulations of the 
Securities and Exchange Commission.  All assets are valued at fair value as 
determined in good faith by, or under the direction of, the Board of 
Directors. See the Asset Valuation Policy Guidelines in the Footnote to 
Schedule of Investments. 

     Securities Transactions.  Securities transactions are accounted for on 
the date the securities are purchased or sold (trade date); dividend income 
is recorded on the ex-dividend date; and interest income is accrued as 
earned.  Realized gains and losses on investment transactions are determined
on the first-in, first-out basis for financial reporting and tax reporting 
or purposes.
       
     Income Taxes.  Prior to January 1, 1998, the Company recorded income 
taxes using the liability method in accordance with the provision of 
Statement of Financial Accounting Standards No. 109.  Accordingly, deferred
tax liabilities had been established to reflect temporary differences 
between the recognition of income and expenses for financial reporting and 
tax purposes, the most significant difference of which relates to the 
Company's unrealized appreciation on investments.

                                      34

     The December 31, 1998 financial statements include a provision for 
deferred taxes on the net unrealized gains as of December 31, 1998, net of 
the operating and capital loss carryforwards incurred by the Company 
through December 31, 1998.  (See Note 6.  Income Taxes.)

     Reclassifications.  Certain reclassifications have been made to the 
December 31, 1996 and December 31, 1997 financial statements to conform to 
the December 31, 1998 presentation.

     Estimates by Management.  The preparation of the financial statements in
conformity with Generally Accepted Accounting Principles requires management 
to make estimates and assumptions that affect the reported amounts of assets 
and liabilities as of December 31,1998 and 1997, and the reported amounts of 
revenues and expenses for the three years ended December 31, 1998.  Actual 
results could differ from these estimates.

NOTE 3.  STOCK OPTION PLAN AND WARRANTS OUTSTANDING

     On August 3, 1989, the shareholders of the Company approved the 1988 
Long Term Incentive Compensation Plan.  On June 30, 1994, the shareholders 
of the Company approved various amendments to the 1988 Long Term Incentive 
Compensation Plan: 1) to conform to the provisions of the BDC regulations 
under the 1940 Act, which allow for the issuance of stock options to 
qualified participants; 2) to increase the reserved shares under the amended
plan; 3) to call the plan the 1988 Stock Option Plan, as Amended and 
Restated (the "1988 Plan"); and 4) to make various other amendments.  On 
October 20, 1995, the shareholders of the Company approved an amendment to 
the 1988 Plan authorizing automatic 20,000 share grants of non-qualified 
stock options to newly elected non-employee directors of the Company.  The 
Company's 1988 Plan was cancelled as of December 31, 1997, canceling all 
outstanding stock options and eliminating all potential stock option grants.
As a substitution for the 1988 Stock Option Plan, the Company adopted an 
employee profit-sharing plan.

     The Company accounted for the 1988 Plan under APB Opinion No. 25, under 
which no compensation cost has been recognized.  Had compensation cost for 
the 1988 Plan been determined consistent with the fair value method required
by FASB Statement No. 123 ("FASB No. 123"), the Company's net realized loss 
and net asset value per share would have been reduced to the following pro-
forma amounts:  

<TABLE>
        <S>                       <C>       <C>              <C>
                                  1998              1997              1996
        Net Realized Loss:             
        As Reported                N/A      $(3,577,818)     $ (3,756,240)
        Pro Forma                  N/A      $(3,921,583)     $ (4,197,096)

        Net Asset Value per share:            
        As Reported                N/A            $3.15             $3.44
        Pro Forma                  N/A            $3.12             $3.40
</TABLE>

     The fair value of each option grant is estimated on the date of grant 
using the Black-Scholes option pricing model with the following weighted 
average assumptions:

<TABLE>
<S>                               <C>              <C>               <C>
                                  1998             1997              1996

         Stock volatility          N/A             0.60              0.60
         Risk-free interest rate   N/A              6.3%              6.8%
         Option term in years      N/A                7                 7
         Stock dividend yield      N/A              - -               - -

</TABLE>
                                       35

     A summary of the status of the Company's 1988 Plan at December 31, 1997 
and 1996 and changes during the years then ended is presented in the table 
and narrative below:
                                                                             
<TABLE>
<S>                                 <C>        <C>        <C>        <C>
                                    December 31, 1997     December 31, 1996
                                    -------------------   -------------------
                                    Shares     Weighted   Shares     Weighted
                                               Average               Average
                                    ---------  --------   ---------  --------
                                               Exercise              Exercise
                                               Price                 Price
                                               --------              --------
Outstanding at beginning of year    1,080,000   $4.584    1,050,000   $4.445

Granted                               300,000   $3.875      160,000   $5.008

Exercised                             158,000   $1.603       50,000   $1.750

Forfeited                             397,000   $5.267       80,000   $5.375

Expired                                 - -       - -          - -      - -

Canceled                              825,000   $4.569         - -      - -

Outstanding at end of year                  0        0    1,080,000   $4.584

Exercisable at end of year                  0        0      390,000   $3.334

Weighted average fair value 
of options granted                      $2.50      - -       $3.222      - -

</TABLE>

     During 1997, the Chairman of the Company exercised a warrant to purchase
237,605 shares of common stock at a price of $2.0641.

     As of January 1, 1998, the Company began implementing the Harris &
Harris Group, Inc. Employee Profit Sharing Plan (the "Plan") that provides
for profit sharing equal to 20 percent of the net realized income of the
Company as reflected on the statement of operations of the Company for such
year, less the nonqualifying gain, if any.  Under the Plan, net realized
income of the Company includes investment income, realized gains and losses,
and operating expenses (including taxes paid or payable by the Company), but
it will be calculated without regard to dividends paid or distributions made
to shareholders, payments under the Plan, unrealized gains and losses, and
loss carry-overs from other years ("Qualifying Income").  The portion of net
after-tax realized gains attributable to asset values as of September 30,
1997 will be considered nonqualifying gain, which will reduce "Qualifying
Income."

     As soon as practicable following year end, the Board of Directors will
determine whether, and if so how much, "Qualifying  Income" exists for a plan
year, and 90 percent of the Qualifying Income will be paid out to Plan
participants pursuant to the distribution percentages set forth in the Plan. 
The remaining 10 percent will be paid out after the Company has filed its
federal tax return for that year in which "Qualifying Income" exists.  The
distribution amounts for each officer and employee is as follows:  Charles
E. Harris, 13.790%; Mel P. Melsheimer, 4.233%; Rachel M. Pernia, 1.524%; and
Jacqueline M. Matthews, 0.453%.  If a participant leaves the Company for
other than cause, the amount earned will be accrued and paid to such
participant, and the remaining amount allocable under the Plan will be
redistributed by the Compensation Committee and paid to the other
participants.  

                                   36

     Notwithstanding any provisions of the Plan, in no event may the
aggregate amount of all awards payable for any Plan year during which the
Company remains a "business development company" within the meaning of the
Investment Company Act of 1940, as amended (the "1940 Act"), be greater than
20 percent of the Company's "net income after taxes" within the meaning of
Section 57(n)(1)(B) of the 1940 Act.  In the event the awards exceed such
amount, the awards will be reduced pro rata.

     The Plan may be modified, amended or terminated by the Company's Board
of Directors at any time; provided however, no such modification, amendment
or termination may adversely affect any participant that has not consented
to such modification, amendment or termination.

     The Company calculates the Plan accrual at each quarter end based on
the unrealized gains at that date, net of operating expenses for the year. 
Any adjustments to the Plan accrual are then reflected in the Statement of
Operations for the quarter.  The Plan accrual is not paid out until the
gains are realized.  During 1998, the Company accrued bonus expense of
$899,751, bringing the cumulative accrual under the Plan to $1,323,559 at
December 31, 1998.

NOTE 4.  CAPITAL TRANSACTIONS

     In 1998, the Board of Directors approved that effective January 1,
1998, 50 percent of all Director fees be used to purchase Company common
stock from the Company.  However, effective on March 1, 1999, the Directors
may purchase the Company's common stock in the market, rather than from the
Company.  During 1998, the directors bought a total of 24,491 shares.

     On April 15, 1998, the Company announced that the Board of Directors
had approved the purchase of up to 700,000 shares of Company stock in the
open market.  As of December 31, 1998, the Company had purchased a total of
126,230 shares for a total of $254,786 or an average of $2.02 per share. 
However, the treasury shares purchased were decreased by the director
purchases of a total of 24,491 shares of Company stock.

NOTE 5.  EMPLOYEE BENEFITS

     The Company has an employment and severance contract ("Employment
Contract") with its Chairman, Charles E. Harris, pursuant to which he is to
receive compensation in the form of salary and other benefits.  On January 1,
1998, Mr. Harris's Employment Contract was amended to reduce his salary to
$200,000 and to allow him to participate in other business opportunities and
investments.  The term of the contract expires on December 31, 1999.  Base
salary is to be increased annually to reflect inflation and in addition may be
increased by such amount as the Compensation Committee of the Board of
Directors of the Company deems appropriate.  In addition, Mr. Harris would be
entitled, under certain circumstances, to receive severance pay under the
employment and severance contracts.

     As of January 1, 1989, the Company adopted an employee benefits program
covering substantially all employees of the Company under a 401(k) Plan and
Trust Agreement.  During 1998, contributions to the plan that have been charged
to operations totaled approximately $37,000.

     On June 30, 1994, the Company adopted a plan to provide medical and
health insurance for retirees, their spouses and dependents who, at the time of
their retirement, have ten years of service with the Company and have attained
50 years of age or have attained 45 years of age and have 15 years of service
with the Company. On February 10, 1997, the Company amended this plan to
include employees who "have seven full years of service and have attained 58
years of age."  The coverage is secondary to any government provided or

                                   37

subsequent employer provided health insurance plans.  Based upon actuarial
estimates, the Company provided an original reserve of $176,520 that was
charged to operations for the period ending June 30, 1994.  As of December 31,
1998 the Company had a reserve of $283,305 for the plan.

NOTE 6.  INCOME TAXES 

     As of December 31, 1998, the Company had not elected tax treatment
available to RICs under Sub-Chapter M of the Code.  Accordingly, for federal
and state income tax purposes, the Company is taxed at statutory corporate
rates on its income, which enables the Company to offset any future net
operating losses against prior years' net income.  The Company may carry back
operating losses against net income two years and carryforward such losses 15
years.

     For the years ended December 31, 1998, 1997 and 1996, the Company's
income tax (benefit) provision was allocated as follows:

<TABLE>
<S>                            <C>            <C>                <C>
                                      1998          1997                1996

Investment operations           $(234,188)    $  (933,103)       $  (680,834)
Realized loss on investments            0      (1,119,825)        (1,327,401)
Increase in unrealized 
 appreciation on investments      592,986         521,900          1,597,748
Total income tax (benefit)      ----------    ------------       ------------
 provision                      $ 358,798     $(1,531,028)       $  (410,487)
                                ==========    ============       ============

The above tax (benefit) provision consists of the following:
                                                                               
Current -- Federal              $  95,430     $         0        $(2,047,304)
Deferred -- Federal               263,368      (1,531,028)         1,636,817
Total income tax (benefit)      ---------     ------------       ------------
 provision                      $ 358,798     $(1,531,028)       $  (410,487)
                                =========     ============       ============
</TABLE>                                     

         The Company's net deferred tax liability at December 31, 1998 and 
1997 consists of the following:

<TABLE>
<S>                                            <C>            <C>
                                                     1998            1997

Unrealized appreciation on investments         $ 3,410,885    $ 2,817,898
Net operating and capital loss carryforward     (2,479,821)    (1,856,989)
Medical retirement benefits                          - -          (81,345)
Other                                                - -         (211,867)
                                               ------------   ------------
Net deferred income tax liability              $   931,064    $   667,697
                                               ============   ============
</TABLE>

         On September 25, 1997, the Company's Board of Directors approved a
proposal to seek qualification as a RIC under Sub-Chapter M of the Code.  As 
a RIC, the Company annually must distribute at least 90 percent of its 
investment company taxable income as a dividend and may either distribute or
retain its taxable net capital gains from investments.  To initially qualify
as a RIC, among other requirements, the Company had to pay a dividend to 
shareholders equal to the Company's cumulative realized earnings and profits
("E&P").   On April 9, 1998, the Company declared a one-time cash dividend 
of $0.75 per share to meet this requirement (for a total of $8,019,728).  
The cash dividend was paid on May 12, 1998.  Continued qualification as a 
RIC requires the Company to satisfy certain portfolio diversification 
requirements in future years.  The Company's ability to satisfy those 
requirements may not be controllable by the Company.  (See "Item 7. 
Management's Discussion and Analysis of Financial Condition and Results of 
Operation - Recent Developments - Sub-Chapter M Status.")

                                    38

         The Company incurred net ordinary and capital losses for a total of
approximately $7.1 million (which results in a tax credit of approximately 
$2.5 million) during its C Corporation taxable years that remain available 
for use and may be carried forward to its 1999 and subsequent taxable years. 
Ordinarily, a corporation that elects to qualify as a RIC may not use its loss
carryforwards from C Corporation taxable years to offset RIC investment 
company taxable income or net capital gains.  In addition, a corporation 
that elects to qualify as a RIC continues to be taxable as a C Corporation 
on any gains realized within 10 years of its qualification as a RIC from 
sales of assets that were held by the corporation on the effective date of 
the election ("C Corporation Assets") to the extent of any gain built into 
the assets on such date ("Built-In Gain").  On February 17, 1999, the 
Company received a ruling from the IRS concluding that the Company can 
carry forward its C Corporation losses to offset any Built-In Gains 
resulting from sales of its C Corporation Assets.  That ruling may enable 
the Company to retain some or all of the proceeds from such sales without 
disqualifying itself as a RIC or incurring corporate level income tax, 
depending on whether the Company's sale of C Corporation Assets with Built-
In Gains will generate C Corporation E&P.  In general, a RIC is not 
permitted to have, as of the close of any RIC taxable year, E&P accumulated 
during any C Corporation taxable year.  However, because the realization of 
Built-In Gains will occur while the Company is a RIC, a strong argument 
exists that, under current law and IRS pronouncements, the sale of C 
Corporation Assets with Built-In Gains during RIC taxable years will not
generate C Corporation E&P.  The Company intends to use the $7.1 million loss
carryforward (which results in a tax credit of approximately $2.5 million) to
reduce its taxes which are due to Built-In Gains.  The December 31, 1998 NAV
includes the utilization of ordinary and capital loss carryforwards of
approximately $0.23 per share.  The IRS recently announced an intention to
issue formal guidance in 1999 concerning conversions of C Corporations to RICs. 
Such guidance may include resolution of the E&P issue described above and 
other issues relevant to the Company.

         There can be no assurance that the Company will qualify as a RIC or 
that, if it does qualify, it will elect RIC status.

         

NOTE 7.  COMMITMENTS AND CONTINGENCIES

         During 1993, the Company signed a ten-year lease with sublet 
provisions for office space.  In 1995, this lease was amended to include 
additional office space.   Rent expense under this lease for the year ended 
December 31, 1998, was $159,515.  Future minimum lease payments in each of 
the following years are: 1999 -- $176,030; 2000 -- $178,561; 2001 -- 
$178,561; 2002 -- $178,561; 2003 -- $101,946. 
         
         In December 1993, the Company and MIT announced the establishment 
by the Company of the Harris & Harris Group Senior Professorship at MIT.  
Prior to the arrangement for the establishment of this Professorship, the 
Company had made gifts of stock in start-up companies to MIT.  These gifts, 
together with the contribution of $700,000 in cash in 1993, which was 
expensed by the Company in 1993, were used to establish this named chair.  
During 1993, 1994 and 1995, the Company contributed to MIT securities which 
were applied to the MIT Pledge at their market value at the time the shares 
became publicly traded or otherwise monetized in a commercial transaction 
and were free from restriction as to sale by MIT.  On December 31, 1998, 
the Company finalized the establishment of the Harris & Harris Group Senior 
Professorship by making the final payment of $728,862 due on the pledge.

                                     39

         In June 1997, the Company agreed to provide one of its investee 
companies with a $450,000 revolving line of credit, of which $50,000 had 
been used through December 31, 1997.  During 1998, through September 30, 
1998, the investee company borrowed an additional $250,000 which was repaid 
in the fourth quarter of 1998.

         In December 1997, the Company signed a Demand Promissory Note for a
$4,000,000 line of credit with J.P. Morgan collateralized by the Company's U.S.
Treasury obligations.  In March 1998, the line of credit was increased to
$6,000,000.  As of December 31, 1997, the Company had borrowed $4,000,000
against the line of credit.  From December 31, 1997 to January 2, 1998, the
rate on the line of credit was prime (8.5 percent).  From January 2, 1998 to
April 2, 1998, the interest rate on the line of credit was LIBOR plus 1.5
percent (7.3125 percent).  In March 1998, the Company paid down $2,500,000; 
in April 1998, the Company paid the remaining balance and did not draw 
against the line for the remainder of the year.

         
NOTE 8.  SUBSEQUENT EVENTS

         On February 22, 1999, NBX Corporation announced that it had agreed 
to be acquired by 3Com Corporation for approximately $90 million in cash plus
additional consideration for employees of NBX.  This transaction was effective
on March 5, 1999 and closed on March 8, 1999.  On closing, the Company received
a total of $12,432,940 in cash, of which $1,475,276 was placed in a one-year
escrow.

         On February 23, 1999, the Board of Directors of the Company declared a
cash dividend of $0.35 per share (approximately $3.7 million) to shareholders
of record on March 19, 1999, payable on March 25, 1999.

         On March 18, 1999, the Company invested $1,000,000 in the equity of 
a privately held medical device company with a patented product addressing a 
very large potential market.  At this writing, the Company is still under 
non-disclosure with respect to the identity of this company.  But this 
investment is the Company's first private equity commitment of part of the 
proceeds from the capital gains generated by the sale of NBX.  

                                    40

<TABLE>
<CAPTION>
                        SELECTED PER SHARE DATA AND RATIOS

         
Per share operating performance:

<S>                 <C>         <C>          <C>         <C>        <C> 
                    Year Ended  Year Ended   Year Ended  Year Ended Year Ended
                       December   December     December    December   December
                       31, 1998   31, 1997     31, 1996    31, 1995   31, 1994

Net asset value, 
beginning of period $      3.15 $     3.44 $       3.54  $     3.43  $    3.66

  Net operating 
   loss                   (0.26)     (0.14)       (0.12)      (0.11)     (0.25)
  Net realized 
   (loss) gain on
   investments            (0.16)     (0.19)       (0.24)       0.14       0.01
  Net increase 
   (decrease) in 
   unrealized
   appreciation 
   as a result of 
   sales                   0.11      (0.17)        0.16       (0.01)     (0.11)
  Net increase in 
   unrealized
   appreciation on
   investments held        0.05       0.26         0.13        0.03       0.01
  Net decrease as 
   a result of 
   dividend               (0.75)       --          --           --         --  
  Net (decrease) 
   increase from 
   capital stock 
   transactions           (0.01)      (0.05)      (0.03)       0.06       0.11
                    ----------- ------------ ---------- -----------  ---------
Net asset value, 
end of period       $      2.13 $      3.15  $     3.44  $     3.54  $    3.43
                    =========== ===========  ==========  ==========  =========
Market value per 
share, end of 
period*             $      1.50 $      3.50  $     3.75  $    7.875  $   6.375

Deferred income 
tax per share       $      0.09 $      0.06  $     0.21  $    0.050  $   0.030

Ratio of expenses 
to average net 
assets                     10.9%        9.1%        8.1%        8.3%      13.6%

Ratio of net 
operating loss to 
average net assets       (10.4)%      (4.5)%      (3.5)%      (3.2)%     (7.1)%

Investment return 
based on:
Stock price              (45.5)%      (6.7)%     (52.4)%       23.5%    (22.7)%
Net asset value          (11.3)%      (8.4)%      (2.8)%        3.2%     (6.3)%

Portfolio turnover        19.71%       77.2%       51.3%       51.2%     136.4%

Net assets, end of 
period              $22,556,709 $33,654,934 $35,932,603 $36,561,909 $31,310,802


Number of shares 
outstanding          10,591,232  10,692,971  10,442,682  10,333,902   9,136,747
  
</TABLE>

*The market value as of December 31, 1998 reflects the decline in market 
price as a result of the $0.75 dividend paid on May 12, 1998.
          
       The accompanying notes are an integral part of this schedule.

                                       41

Item 9.  Disagreements on Accounting and Financial Disclosure

     None.

  
                                     PART III

Item 10. Directors and Executive Officers of the Company

     The information set forth under the captions "Election of Directors" 
on page 2, "Executive Officers" on page 8 and "Section 16(a) Beneficial 
Ownership Reporting Compliance" on page 13 in the Company's Proxy Statement 
for Annual Meeting of Shareholders to be held April 28, 1999, filed pursuant 
to Regulation 14A under the Securities Exchange Act of 1934 on or about 
March 24, 1999 (the "1999 Proxy Statement") is herein incorporated by 
reference.


Item 11. Executive Compensation

      The information set forth under the captions "Summary Compensation 
Table" on pages 9 and 10 and "Compensation of Directors" on page 12 in the 
1999 Proxy Statement is herein incorporated by reference.


Item 12. Security Ownership of Certain Beneficial Owners and Management

      The information set forth under the caption "Security Ownership of 
Directors and Executive Officers and other principal holders of the 
Company's voting securities" on page 7 in the 1999 Proxy Statement is 
herein incorporated by reference.


Item 13. Certain Relationships and Related Transactions

      There were no relationships or transactions within the meaning of this
item during the year ended December 31, 1998.

                                   42

                                 PART IV

Item 14. Exhibits, Financial Statements, Schedules and Reports on Form 8-K

(a)     The following documents are filed as a part of this report:

        (1) The following Financial Statements of the Company are set forth 
            under Item 8:

            Statements of Assets and Liabilities as of December 31, 1998 and
            1997
            Statements of Operations for the years ended December 31, 1998, 
            1997 and 1996
            Statements of Cash Flows for the years ended December 31, 1998, 
            1997 and 1996
            Statements of Changes in Net Assets for the years ended 
            December 31, 1998, 1997 and 1996
            Schedule of Investments as of December 31, 1998
            Footnote to Schedule of Investments
            Notes to Financial Statements
            Selected Per Share Data and Ratios for the years ended December 
            31, 1998, 1997, 1996, 1995 and 1994

        (2) Report of Independent Public Accountants.

        (3) The following exhibits are filed with this report or are 
            incorporated herein by reference to a prior filing, in 
            accordance with Rule 12b-32 under the Securities Exchange Act 
            of 1934.  (Asterisk denotes exhibits filed with this report.) 

         3.1(a) Restated Certificate of Incorporation of the Company, as 
                amended, incorporated by reference to Exhibit 3.1 (a) to 
                the Company's Form 10-K for the year ended December 31, 1995.

         3.1(b) Restated By-laws of the Company, incorporated by reference to
                Exhibit 3.1(b) to the Company's Form 10-K for the year ended 
                December 31, 1995 and the Company's Form 10-Q for the quarter
                ended September 30, 1998.

         4.1    Specimen certificate of common stock certificate, 
                incorporated by reference to Exhibit 4 to Company's 
                Registration Statement on Form N-2 filed October 29, 1992.

         9.1    Harris & Harris Group, Inc. Custodian Agreement with JP Morgan,
                incorporated by reference to Exhibit 9.1 to the Company's Form 
                10-K for the year ended December 31, 1995.

        10.1    Amended and Restated Employment Agreement between Harris & 
                Harris Group, Inc. and Charles E. Harris dated January 1, 1998.

        10.5    Severance Compensation Agreement by and between the Company 
                and Charles E. Harris dated August 15, 1990, incorporated by 
                reference to exhibit 10(s) to the Company's Annual Report on 
                Form 10-K for the year ended December 31, 1990.

        10.13   Stock Purchase Agreement, Standstill Agreement and 
                Termination and Release by and among Harris & Harris Group, 
                Inc. and American Bankers Life Assurance Company of Florida 
                dated May 18, 1995, incorporated by reference to Exhibit 
                10.13 to the Company's Form 10-K for the year ended December 
                31, 1995.  

        10.14   Form of Indemnification Agreement which has been established 
                with all directors and executive officers of the Company, 
                incorporated by reference to Exhibit 10.14 to the Company's 
                Form 10-K for the year ended December 31, 1995.

        10.16   Demand Promissory Note, Corporate Certificate-Borrowing, 
                Statement of Purpose for an Extension of Credit Secured by 
                Margin Stock by and among Harris & Harris Group, Inc. and 
                J.P. Morgan.

        10.17   Harris & Harris Group, Inc. Employee Profit Sharing Plan, 
                incorporated by reference as Exhibit (c) to the Company's 
                Form 8-K filed June 15, 1998.

        11.0*   Computation of Per Share Earnings is set forth under Item 8.

        23*     Consent of Arthur Andersen LLP.

        27.0*   Financial Data Schedule.


(b)     Reports on Form 8-K.  The Company did not file any reports on Form 
        8-K during the last quarter of 1998.

                                    44

SIGNATURES

        Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Company has duly caused this report to be signed 
on its behalf by the undersigned, thereunto duly authorized.

                                            HARRIS & HARRIS GROUP, INC.


Date: March 19, 1999                        By:/s/
                                               ------------------------
                                               Charles E. Harris
                                               Chairman of the Board

    Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the 
Company and in the capacities and on the dates indicated.

Signatures                  Title                          Date

              
/s/                         Chairman of the Board,         March 19, 1999
- -----------------------     Chief Compliance Officer and
Charles E. Harris           Chief Executive Officer
 
/s/                         President, Chief Operating     March 19, 1999
- -----------------------     Officer and Chief Financial 
Mel P. Melsheimer           Officer 


/s/                         Vice President, Controller,    March 19, 1999
- -----------------------     Treasurer and Principal
Rachel M. Pernia            Accounting Officer

                                 45

/s/                         Director                       March 20, 1999
- -----------------------
C. Wayne Bardin                                            


/s/                         Director                       March 18, 1999
- -----------------------
Phillip A. Bauman 


/s/                         Director                       March 18, 1999
- -----------------------
G. Morgan Browne 


/s/                         Director                       March 19, 1999
- -----------------------
Harry E. Ekblom


/s/                         Director                       March 19, 1999
- -----------------------
Dugald A. Fletcher


/s/                         Director                       March 18, 1999
- -----------------------
Glenn E. Mayer


/s/                         Director                       March 19, 1999
- -----------------------
William R. Polk


/s/                         Director                       March 18, 1999
- -----------------------
James E. Roberts                                            

                                      46

EXHIBIT INDEX

    The following exhibits are filed with this report in accordance with Rule 
12b-32 under the Securities Exchange Act of 1934. 

Exhibit No.   Description



11.0  Computation of Per Share Earnings is set forth under Item 8.

23    Consent of Arthur Andersen LLP.

27.0  Financial Data Schedule.
                       
                                     47
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE>  6
<CIK>      0000893739
<NAME>     HARRIS & HARRIS GROUP, INC.
       
<S>                                <C>
<PERIOD TYPE>                      12-MOS
<FISCAL-YEAR-END>                  DEC-31-1998
<PERIOD-END>                       DEC-31-1998
<INVESTMENTS-AT-COST>               14,124,643
<INVESTMENTS-AT-VALUE>              24,532,191
<RECEIVABLES>                          414,036
<ASSETS-OTHER>                         248,489
<OTHER-ITEMS-ASSETS>                         0
<TOTAL-ASSETS>                      25,358,859
<PAYABLE-FOR-SECURITIES>                     0
<SENIOR-LONG-TERM-DEBT>                      0
<OTHER-ITEMS-LIABILITIES>            2,802,150
<TOTAL-LIABILITIES>                  2,802,150
<SENIOR-EQUITY>                              0
<PAID-IN-CAPITAL-COMMON>            16,158,381
<SHARES-COMMON-STOCK>               10,591,232
<SHARES-COMMON-PRIOR>               10,692,971
<ACCUMULATED-NII-CURRENT>                    0
<OVERDISTRIBUTION-NII>                       0
<ACCUMULATED-NET-GAINS>              (525,177)
<OVERDISTRIBUTION-GAINS>                     0
<ACCUM-APPREC-OR-DEPREC>             6,996,664
<NET-ASSETS>                        22,556,709
<DIVIDEND-INCOME>                       52,550
<INTEREST-INCOME>                      480,468
<OTHER-INCOME>                         102,468
<EXPENSES-NET>                       3,634,786
<NET-INVESTMENT-INCOME>            (2,765,112)
<REALIZED-GAINS-CURRENT>           (1,768,528)
<APPREC-INCREASE-CURRENT>           1,655,830
<NET-CHANGE-FROM-OPS>              (2,877,810)
<EQUALIZATION>                               0
<DISTRIBUTIONS-OF-INCOME>          (8,019,728)
<DISTRIBUTIONS-OF-GAINS>                     0
<DISTRIBUTIONS-OTHER>                        0
<NUMBER-OF-SHARES-SOLD>                      0
<NUMBER-OF-SHARES-REDEEMED>                  0
<SHARES-REINVESTED>                          0
<NET-CHANGE-IN-ASSETS>            (10,897,538)
<ACCUMULATED-NII-PRIOR>                      0
<ACCUMULATED-GAINS-PRIOR>                    0
<OVERDISTRIB-NII-PRIOR>                      0
<OVERDIST-NET-GAINS-PRIOR>                   0
<GROSS-ADVISORY-FEES>                        0
<INTEREST-EXPENSE>                           0
<GROSS-EXPENSE>                              0
<AVERAGE-NET-ASSETS>                28,105,821
<PER-SHARE-NAV-BEGIN>                     3.15
<PER-SHARE-NII>                         (0.42)
<PER-SHARE-GAIN-APPREC>                   0.16
<PER-SHARE-DIVIDEND>                      0.75
<PER-SHARE-DISTRIBUTIONS>                    0
<RETURNS-OF-CAPITAL>                         0
<PER-SHARE-NAV-END>                       2.13
<EXPENSE-RATIO>                           10.9
<AVG-DEBT-OUTSTANDING>                       0
<AVG-DEBT-PER-SHARE>                         0
                         

</TABLE>

                     CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

     As independent public accountants, we hereby consent to the incorporation
by reference in this Form 10-K of our report dated February 10, 1999.  It 
should be noted that we have not audited any financial statements of the 
company subsequent to December 31, 1998 or performed any audit procedures 
subsequent to the date of our report.

                                          /s/  Arthur Andersen LLP
                                          ------------------------

New York, New York
March 25, 1999


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission